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The Wnt-signaling transduction cascade plays critical roles in embryonic
patterning, cell fate determination and tissue homeostasis. When secreted Wnt
factors bind to their receptors, a set of biochemical changes is set in motion,
ultimately resulting in the accumulation of unphosphorylated b-catenin and its
translocation to the nucleus. In the nucleus, b-catenin binds to members of the
TCF/LEF family of transcription factors, the most downstream components of
the Wnt-signaling pathway. In this review, a comprehensive overview of this
tightly regulated cascade is given.
The TCF/LEF family of transcription factors
The founding members of the TCF/LEF family of transcription factors,
TCF1 and LEF-1, were identified in screens for T-cell specific transcription
factors. TCF1 was identified by its ability to bind to the CD3e enhancer,
whereas LEF-1 was found in a screen for proteins binding to the TCRa enhancer
and a site in the HIV LTR (Oosterwegel et al., 1991; van de Wetering et al.,
1991; Travis et al., 1991; Waterman et al., 1991). In more recent years, two
additional family members were identified in mammals: TCF3 and TCF4. The
Drosophila genome only contains one TCF gene, called dtcf or pangolin
(Brunner et al., 1997; van de Wetering et al., 1997; ). Similarly, a single gene
resides in the genome of the nematode C. elegans, Pop-1 (Lin et al., 1995), as
well as a Lef homologue gene has been identified in chicken (Kengaku et al.,
1998).
TCF structure
Proteins of the TCF/LEF family contain a high mobility group (HMG) box
which mediate DNA-binding. HMG boxes bind DNA as monomers (Grosschedl et
al., 1994; Laudet et al., 1993) in a sequence-specific manner (Laudet et al.,
1993). The TCF consensus recognition sequence is remarkably conserved
between the family members, and comprises AGATCAAAGGG (van de Wetering
et al., 1991; Giese et al., 1991; van Beest et al.,2000). The HMG box not only
mediates binding to DNA, it also induces a dramatic bend in the DNA (Giese et
al., 1992; Dooijes et al., 1993). By doing so HMG boxes coordinate the binding
of other transcription factors (Grosschedl et al., 1994; Giese et al., 1995;
Bianchi and Beltrame, 1998). Because of its bending ability and the observation
that TCF factors cannot directly activate transcription in reporter assays, it was
proposed that TCF/LEF family members primarily serve an architectural
function. LEF-1 appears unique in that it contains a context-dependent
activation domain (CAD) (Carlsson et al., 1993), which can activate
transcription in the presence of the co-activator ALY (Bruhn et al., 1997). As
TCF1 does not contain a CAD domain, it is incapable of activating the TCRa
enhancer (van de Wetering et al., 1996).
TCF/Lef mRNAs undergo extensive alternative splicing, which has best
been described for TCF1. In addition, alternative promoter usage occurs in the
TCF1 gene, which results in the predominant expression of eight different TCF1
protein isoforms (van de Wetering et al., 1996). LEF-1 exhibits two splice
variants (Waterman et al., 1991), and also possesses two promoters (Hovanes
et al., 2001). At least three splice variants exist of TCF4 (Korinek et al., 1997;
Duval et al., 2000) (Fig.1).
The HMG box and the b-catenin binding domains show the highest
homology between the Tcf’s of one specie but also if compared to molecules of
different species. The similarities are more striking than the differences. DTcf is
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rather unique as it has an alternative exon encoding the second part of the
HMG box. This alternative protein is called dTCFB, which is not expressed
during embryogenesis (van de Wetering et al., 1997). The function of the
different splice variants of Tcf1, Tcf4, dTcf and Lef-1 is unresolved so far,
though the Tcf-1 protein lacking the b-catenin binding domain has been shown
to act as a tumor suppressor as it actively represses Wnt signaling targets (see
below, Roose et al., 1999). The C-terminus of the longer versions of Tcf-1 and
Tcf-4 contain the so called CRARF box. Mutations in the CRARF-box of dTcf are
lethal to the flies (van de Wetering et al., 1997), however, the function of this
conserved region remains unresolved (Moniek van Beest, unpublished data).
Fig. 1 Schematic representation of Tcf splice variants and their most conserved
domains. Short forms of Tcf-1 lack the N-terminal domain, which interacts with b-
catenin. The most distinct regions of the Tcf family members is the C-terminus, which
contains the CRARF domain in the longer versions.
Tcf/Lef-/- mice
As the molecular context in which the TCF family of transcription
factors functions remained mysterious for years, knockout mice have
been generated for three murine Tcfs. In adult animals, Tcf1 is
expressed in T-lymphocytes and the Tcf1 -/- knockout mice are impaired
in the generation of T-cells (Verbeek et al., 1995). Their thymi are
reduced in size and show a 10-100 fold reduction in T cell numbers
compared to heterozygous littermates. T-cell differentiation is halted at
the transition from the CD8+ immature single positive to the
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CD4+CD8+ double positive stage (Verbeek et al., 1995). Nevertheless,
the Tcf1-/- mice are fully immuno-competent, have functional peripheral
T cells, have a normal lifespan, and are fertile (Schilham et al., 1998).
Closer examination of the thymocytes from 4-6 weeks old animals
revealed blockades at the CD44+CD25+ and CD44-CD25- stages,
which are normally characterized by extensive cell expansion (Schilham
et al., 1998). However, the T-cells, which are found in circulation, have
an activated phenotype and proliferate normally after encountering
mitogens or antigens. More recently, it was found that Tcf1-/- mice
develop adenomas in the gut and the mammary glands, which resulted
in the hypothesis that Tcf1 is a target gene of Tcf4/b-catenin signaling
in the intestine (Roose et al., 1999). Predominantly the isoform of Tcf1
is expressed, which lacks the b-catenin interaction domain. This
isoform is able to bind Grg’s (see below), resulting in target gene
repression. Tcf1 as a target of Tcf4 would thereby act as a feedback
repressor of b-catenin/Tcf4 target genes (Roose et al., 1999).
Lef-1-/- knockout mice have a more complex phenotype. During
embryogenesis, Lef-1 is expressed at many different sites for instance
the tel-, di-, and mesecephalon, neural crest, mesencephalic nucleus of
the trigeminal nerve, pituitary gland, inner ear, tongue, upper and
lower lips, nasal process, tooth germs, whisker follicles, mammary
buds, lung, kidney, thymus, limb buds, and tail vertebrae (Oosterwegel
et al., 1993; Zhou et al., 1995; van Genderen et al., 1994). Mice
homozygous for a mutation in the Lef gene die shortly after birth and
show deficiencies in some but not all organs normally expressing Lef-1
(van Genderen et al., 1994). Most strikingly, these mice lack body hair
and whiskers. Although follicle formation starts at the proper time
point, only one third of normal follicle numbers is found later in
development, which are short and rudimentary. These Lef-1-/- mice
lack also teeth: though the tooth germs are indistinguishable from wild
type counterparts at the bud stage (E13), normal progression of the
Lef-1-/- buds to the late cap stage (E15) is halted (van Genderen et al.,
1994). Newborn Lef1-/- females reveal a lack of mammary glands. At
day 13.5 after gestation, all three thoracic and one of the two inguinal
mammary buds are present in the wild type embryos, whereas the Lef-
1-/- mice display severely reduced numbers. Although Lef-1 is
expressed in many parts of the nervous system, the mutant mice lack
only the trigeminal nucleus. Unexpectedly these mice did not show any
obvious defects in lymphoid cell populations at birth, despite the fact
that Lef-1 is expressed in B-cells, (van Genderen et al., 1994). In
contrast it was shown in a recent study, that Lef-1 mediates
proliferation of early B lineage cells in vitro (Reya et al., 2000).
The Tcf1-/-/Lef-1-/- double knockout mouse shows severe
impaired T cell differentiation. a/b T cell differentiation is completely
blocked at the immature single positive (ISP) stage and clearly
impaired at earlier stages (Okamura et al., 1998). The overall
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phenotype resembles the Wnt-3A-/- phenotype. Gene disruption of both
genes causes severe defects in differentiation of the paraxial mesoderm
and results in the formation of additional neural tubes. These embryos
also show defects in placenta formation, limb bud development and in
forming an apical ectodermal ridge. These data indicate redundancy in
Tcf1 and Lef-1 expression during mouse development (Galceran et al.,
1999).
Tcf4 is expressed from E10.5 onwards in the developing CNS,
coinciding with Lef-1 expression. This gene is also expressed at day
13.5 after gestation directly before the transition of gut endoderm into
epithelium. Tcf4 expression remains in the gut epithelium throughout
life (Korinek et al., 1997; Korinek et al., 1998a). Tcf4-/- mice die shortly
after birth, and display a single phenotypic abnormality, the complete
absence of the stem cell compartment in the crypts of the small
intestine (Korinek et al., 1998b). The organization of the stratified
epithelium in the small intestine of mutant embryos shows no
aberrations at day 14.5 compared to control littermates. At day 16.5,
however, a reduced number of cells populates the prospective crypt
region and the number of villi is reduced (Korinek et al., 1998b). Closer
examination of the cells populating the prospective crypt regions
reveals a lack of actively dividing, future crypt cells. Despite these
dramatic phenotypes, the mechanisms by which the TCF/LEF family
members operate remained unclear.
Binding partners of TCF
The identification of binding partners of TCF would eventually
resolve this question. The first protein found to interact with TCF/LEF
factors was b-catenin, identified in a yeast two-hybrid screen (Molenaar
et al., 1996; Behrens et al., 1996). Using multimerised TCF binding
motifs in front of a reporter gene, it became apparent that co-
transfection of TCF with b-catenin strongly induced transcription
(Molenaar et al., 1996). All members of the TCF family can bind b-
catenin, through their conserved N-terminus.
Another binding partner of TCF was identified, Grg-5, was also
identified in a yeast two-hybrid screen. Grg-5 is related to Drosophila
Groucho, which in turn is the founding member of a family of broadly
expressed transcriptional co-repressors. Mouse Grg-5 contains 2
domains, whereas the longer family members harbor 5 domains. Grg
proteins interact with histone de-acetylase-1, which results in
condensing of the chromatin (Chen et al., 1999). In a transient
reporter assay, the transcription driven by b-catenin/TCF could
completely be repressed by titrating in Grg expression constructs
(Roose et al., 1998; Cavallo et al., 1998). The shorter Grg family
member, Grg-5, fails to bind to HDAC, acting thereby as a de-repressor
(Roose et al., 1998; Brantjes et al., 2001). All members of the TCF
family can bind to all Grgs and all combinations with the HDAC binding
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Grg proteins appear to be equally potent in repressing transcription
(Brantjes et al., 2001). The mechanism by which active repression
(Tcf/Groucho) is replaced by active transactivation (Tcf/b-catenin) is
currently unresolved. The binding domains of Grg and b-catenin binding
domains in Tcf are not overlapping, thus forming a trimeric complex
should be possible (Roose et al., 1998).
Another co-repressor of TCF was identified as the CREB binding
protein (CBP) (Waltzer and Bienz, 1998). This was rather surprising, as
CBP is a strong co-activator for dozens of other transcription factors.
CBP binds to the HMG box and subsequently acetylates a specific lysine
in the N-terminal b-catenin interaction domain. This leads to decreased
binding of b-catenin to TCF, resulting in lower transactivation.
However, the lysine, which is acetylated, K25, lacks in the N-termini of
TCF1, POP-1 and Tcf3. This suggests that this mode of modulating b-
catenin/Tcf mediated signaling is dependent on the TCF/Lef family
member. The phenotype of the dCBP mutant embryos, suggests that
this activity of dCBP primarily antagonizes Wnt signaling in cells which
are only stimulated weakly (Waltzer and Bienz, 1998). In the Ras
recruitment system, detecting protein-protein interactions, CBP was
also found to interact with b-catenin. CBP binds to the C-terminal part
of b-catenin, from armadillo repeat 10 onwards. b-catenin synergizes
with CBP to enhancing transcription of a reporter in vivo (Takemaru
and Moon, 2000). These results are more in line with the earlier
described function of CBP as a transcriptional activator.
Finally, the only protein found to function as co-repressor for a
subset of the TCF family was identified by Moon and coworkers. C-
terminal binding protein (CtBP) binds to a sequence only present in the
C-terminus of XTcf3 and TCF4, thereby converting these TCF proteins
into repressors (Brannon et al., 1999). XCtBP was fused to the GAL4
activation domain and this chimera was able to induce siamois
expression, through interacting with endogenous XTcf3. The CtBP
binding domain is also present in hTCF3, therefore TCF3-b-catenin
binding may also be inhibited by CtBP.
TCF and Wnt-signaling
The identification of b-catenin as a binding partner of TCF
answered two questions at once. b-catenin was the most downstream
protein in the Wnt-signaling cascade known at the time, but it was
unclear how b-catenin was able to transduce the signal into the
nucleus, as b-catenin has no DNA binding properties. TCF on the other
hand was known to bind to DNA, but by itself did not regulate
transcription. Now that b-catenin and TCF were found to interact, TCF
could be placed downstream of b-catenin in the Wnt-signaling cascade.
A series of genetic, cell-biological, and molecular studies have identified
the nature and relative order of these components in the Wnt-signaling
cascade.
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The involvement of Tcf in the Wnt-signaling pathway was first
addressed in Xenopus Laevis. The role of b-catenin in head induction
had been known for years (Heasman et al., 1994). Ventral micro-
injection of b-catenin mRNA in embryos induces axis duplication. More
importantly, this phenotype could be prevented by co-injecting mRNA
encoding an XTcf3 protein lacking the b-catenin binding domain. Dorsal
injection of this Tcf mutant could also block endogenous head induction
(Molenaar et al., 1996). Injections of Lef-1 mRNA lacking the HMG box
also inhibited head induction (Behrens et al., 1996; Huber et al.,
1996). These data proved that the direct interaction of b-catenin with
Tcf is essential for normal axis specification in Xenopus and placed it
directly downstream of b-catenin in the Wnt/wg cascade.
Since the experiments in Xenopus largely relied on
overexpression of proteins, definite proof of the role of Tcf in the Wnt
signaling cascade came from genetic experiments in Drosophila. Two
labs independently cloned the fly homologue of Tcf, dTcf or pangolin
(van de Wetering et al., 1997; Brunner et al., 1997). DTcf binds a Tcf
DNA motif and, together with the b-catenin homologue armadillo,
transactivates transcription of reporter genes (van de Wetering et al.,
1997). The final proof was provided by epistasis experiments showing
that loss of function mutations in dTcf are dominant over gain of
function mutations in arm (van de Wetering et al., 1997). The Wg
cascade is important for cell fate determination in Drosophila larvae
and flies. Murine Lef-1 overexpression in transgenic flies mimics
wingless hyperstimulation. The authors show that Lef binds to arm in
vitro thereby suggesting that bypassing the need for wingless by
overexpression of mLef-1 is dependent on arm (Riese et al., 1997). The
extreme high levels of Lef should somehow capture this arm. As the
turn over of arm in non-signaling cells is probably very high due to the
immediate degradation, it is more likely that Lef-1 action is mediated in
a context specific manner as described above (Bruhn et al., 1997).
In the nematode C. Elegans, the story is slightly different as the
signaling function and the role in the adherens junctions are mediated
by different b-catenin homologues. The worm has three b-catenin
homologues: WRM-1, BAR-1 and HMP-2. First it was thought that the
Wnt pathway acted differently, as WRM-1 opposes Wnt signaling to the
Tcf homologue POP-1, rather than mediates Wnt signaling (Lin et al.,
1995; Rocheleau et al., 1999). However, recently published data
demonstrate the presence of a canonical Wnt signaling pathway in C.
elegans. It was shown that BAR-1 acts like b-catenin in activating
target genes in response to Wnt signals. HMP-2 mediates cell-cell
adhesion by binding to the a-catenin homologue HMP-1 and interacting
with the E-cadherin homologue HMR-1 (Korswagen et al., 2000). It is
curious that during evolution the functions of two separate genes are
combined into one single protein, where more often evolution results in
gene duplication.
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Outline of the Wnt pathway
The family of Wnt/wingless proteins constitutes a large family
(> 19 members) of cysteine-rich glycoproteins. Wnts function as
ligands for members of the Frizzled (Fz) family of serpentine receptors
(Bhanot et al., 1996). At least nine different Fz genes have been
identified thus far. Whether Fzs exhibit specificity for certain Wnts is
still subject of investigation. Soluble Fz’s, frizbees (Fzbs) have been
proposed to act as antagonists, capturing Wnt before it can bind to cell
surface bound Fz and trigger the signaling cascade (Leyns et al., 1997;
Wang et al., 1997; Finch et al., 1997).
New evidence from flies, frogs, and mice indicates that the Wnt-
receptor Frizzled is not sufficient for transducing Wnt signals. Recent
results imply that Low-density lipoprotein (LDL) receptor-related
proteins (LRPs) act in synergy with Fz. The extracellular domains of
both proteins interact and signaling of Wnt is only mediated when both
Fz and LRP are complexed with Wnt-1 (Tamai et al., 2000; Pinson et
al., 2000; Wehrli et al., 2000). Some years ago the Dickkopf (dkk)
family was identified as antagonists of Wnt (Glinka et al., 1998). Axis
induction of Xwnt-8 could completely be blocked by co-injecting dkk-1
and the inhibition of Wnt signaling was found at the extra-cellular level.
In subsequent studies, Mao et al. could not detect any interaction
between dkk and Fz. Therefore they hypothesized that dkk may be the
ligand of LRP-6. Indeed, dkk interacts with LRP-6 to a domain adjacent
to the domain interacting with Wnt (Mao et al., 2001a). A recent study
shows that LRP-5 interacts with axin upon binding of Wnt, thereby
destabilizing axin. Consequently b-catenin is stabilized and accumulates
(Mao et al., 2001b). An interesting subject of investigation will be the
intracellular interactions and cooperation of both receptors.
In unstimulated cells, b-catenin resides in a large cytoplasmic
complex consisting of the tumor suppressor APC (adenomatous
polyposis coli), GSK-3b (Glycogen synthase kinase 3b) and Axin. In this
complex, b-catenin is phosphorylated by the serine/threonine kinase
GSK-3b on four N-terminal serine and threonine residues (Behrens et
al., 1998; Kishida et al., 1998; Ikeda et al., 1998). This
phosphorylation is a signal to ubiquitinate and degrade b-catenin
(Orford et al., 1997). Upon Wnt binding to its receptor, the Wnt-
signaling cascade is activated (Fig. 2). This results in the
hyperphosphorylation of Dishevelled, which in turn inhibits the actions
of GSK-3b (Yanagawa et al., 1995). Consequently, b-catenin is no
longer phosphorylated and can accumulate. This non-phosphorylated b-
catenin then translocates to the nucleus where it binds to TCF,
resulting in target gene expression (Behrens et al., 1996; Molenaar et
al., 1996; Brunner et al., 1997; Riese et al., 1997; van de Wetering et
al., 1997).
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Fig. 2 Model of the
Wnt signaling
cascade. This
simplified scheme
depicts the
differences between
a non-signaling cell
and its signaling
counterpart.
b-catenin
b-catenin is a 92 kDa protein which was originally identified as one of
the components of the adherens junction (Nagafuchi and Takeichi, 1989;
Ozawa et al., 1989). In adherens junctions, b-catenin links E-cadherin to a-
catenin, which in turn couples the complex to the actin microfilament network
of the cytoskeleton (Ozawa et al., 1989; Gumbiner, 1993; Cowin, 1994).
Homozygous inactivation of b-catenin results in embryonic lethality at day 6.5
post coitum (Haegel et al., 1995). More detailed analysis of these mice show a
defect in anterior-posterior axis formation at day 5.5 post coitum (Huelsken et
al., 2000).
b-catenin consists of an N-terminal region of approximately 130 amino
acids, a central region of 550 amino acids containing the so called armadillo
repeats, and a C-terminal region of 100 amino acids. The N-terminus contains
the GSK-3b phosphorylation sites and is therefore important for the regulation
of transcriptional activity (Peifer et al., 1994a). The armadillo repeat region
contains a series of 13 imperfect 42 amino acid repeats (Peifer et al., 1994b),
that mediates protein-protein interactions with APC, axin, cadherins and Tcf. X-
ray crystallography of these repeats revealed that they form a super-helix that
features a long, positively charged groove (Huber et al., 1997). Cadherins,
TCFs, APC, and conductin/axin bind within this groove (Huber et al., 1997; von
Kries et al., 2000). The C-terminus harbors the transactivation domain. Fusing
this domain to the GAL4 DNA-binding domain is sufficient for transactivation
(van de Wetering et al., 1997).
The destruction complex
In non-signaling cells, the destruction complex negatively regulates the
intracellular levels of b-catenin. This complex consists of the tumor suppressor
adenomatous polyposis coli (APC), Axin or its counterpart conductin, and GSK-
3b (Fig. 3). APC was identified as the gene responsible for familial
adenomatous polyposis coli, an inherited form of colon cancer (Kinzler and
Vogelstein, 1996; Polakis, 1997; Bienz, 1999). Consistent with its role as a
tumor suppressor, overexpression of APC blocks cell cycle transition from the
G1 to S phase (Baeg et al., 1995). APC is a ubiquitously expressed 300 kDa
protein, present in cytoplasm and nucleus. It is also able to export b-catenin
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from the nucleus to the cytoplasm (Rosin-Arbesfeld et al., 2000). This export is
proposed to transport b-catenin to the destruction complex, where it
subsequently is phosphorylated. Upon phosphorylation of b-catenin at its N-
terminus by GSK-3b, b-catenin is targeted for ubiquitination by interacting with
the adaptor protein b-TrCP. This F-box protein determines the substrate
specificity for ubiquitination by selectively recruiting phosphorylated substrates
via its WD40 repeats (Feldman et al., 1997; Skowyra et al., 1997). b-catenin is
tagged with multiple copies of the small protein ubiquitin (Ciechanover, 1994),
resulting in rapid degradation by the proteasome, a large multisubunit
proteolytic complex (Hart et al., 1999). The specific sites in APC to which b-
catenin binds are three 15-amino acid and seven 20-amino acid repeats, the
latter of which are reported to be responsible for targeting b-catenin for
degradation (Rubinfeld et al., 1997). In addition to its function in regulating b-
catenin levels, APC has been found to play an important role in chromosome
segregation (Fodde et al., 2001; Kaplan et al., 2001), explaining why colon
carcinomas frequently exhibit chromosomal instability.
The constitutively active kinase responsible for b-catenin
phosphorylation and subsequent targeting for degradation is GSK-3b. GSK-3b
has also been implicated in several other signal transduction cascades, e.g.
driven by insulin (Welsh and Proud, 1993), insulin like growth factor 1 (Cross
et al., 1994) and epidermal growth factor (Eldar-Finkelman et al., 1995).
Recently the crystal structure of GSK-3b has been elucidated (Dajani et al.,
2001; ter Haar et al., 2001). The kinase has two types of substrates, i.e.
glycogen synthase and b-catenin, which are phosphorylated in different ways.
Glycogen synthase needs to be pre-phosphorylated at the +4 position of the
substrate serine of GSK-3b. Inhibiting this primed phosphorylation does not
influence phosphorylation of b-catenin, indicating that b-catenin
phosphorylation does not require priming (Thomas et al., 1999).
It has recently been shown that Axin is involved in b-catenin
degradation. It interacts with b-catenin, GSK-3b, and APC (Hart et al., 1998;
Ikeda et al., 1998; Kishida et al., 1998; Nakamura et al., 1998; Sakanaka et
al., 1998). Conductin or Axil, a molecule closely related to Axin, has also been
shown to interact with these proteins (Behrens et al., 1998; Yamamoto et al.,
1998). Mutations in Axin/Conductin result in the accumulation of cytoplasmic b-
catenin, while ectopic expression of Axin inhibits Wnt-signaling (Zeng et al.,
1997). This indicates that Axin negatively regulates Wnt-signaling by down-
regulating b-catenin levels. b-catenin and GSK-3b bind adjacently to the central
region of Axin (Hart et al., 1998; Ikeda et al., 1998; Kishida et al., 1998;
Nakamura et al., 1998; Sakanaka et al., 1998) and it is assumed to facilitate
binding of GSK-3b with b-catenin, acting as a scaffold. Axin has, indeed, been
shown to promote b-catenin phosphorylation by GSK-3b in vitro, though it
remains to be shown in vivo (Ikeda et al., 1998). The C-terminus of Axin
harbors a so-called DIX domain, important for oligomerization. Deleting this
DIX domain abolishes the ability of Axin to down-regulate Wnt-signaling,
indicating that oligomerization of Axin is indispensable for its action (Kishida et
al., 1998; Sakanaka and Williams, 1999; Hsu et al., 1999).
Axin itself is phosphorylated by GSK-3b, and the resulting
hyperphosphorylation is important for its function. Upon Wnt signaling, Axin is
dephosphorylated, resulting in a lower affinity for b-catenin (Willert et al.,
1999; Yamamoto et al., 1999). Dvl may be involved in this down-regulation of
Axin activity, as it interacts with Axin and inhibits the phosphorylation of Axin
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by GSK-3b (Kishida et al., 1999). Dvl has been reported to bind to Axin at two
distinct domains, either between the DIX domains of both proteins or between
the PDZ domain of Dvl and the N-terminal region of Axin (Kishida et al., 1999;
Li et al., 1999).
Target genes of Wnt signaling
Among the best-studied target genes of the Wnt-signaling cascade are
Xenopus Siamois and Twin, dorsal-specific genes required for the activation of
the Spemann organizer and the subsequent development of the dorsal-ventral
axis (Brannon et al., 1997; Laurent et al., 1997). Other candidate target genes
include Xenopus nodal-related 3, and Drosophila Engrailed and Ultrabithorax
(van de Wetering et al. 1997; Riese et al., 1997; Molenaar et al., 1996; Travis
et al., 1991). In mammalian cells, genes like c-MYC (He et al., 1998), cyclin D1
(Tetsu and McCormick, 1999), gastrin (Koh et al., 2000) and PPARd (He et al.,
1999) have been reported to be targets of b-catenin/TCF. For a complete list,
visit the Wnt website: www.ana.ed.ac.uk/rnusse/wntwindow.html. TCF1 has
also been proposed to be a target gene of b-catenin and TCF4 in epithelial cells
(Roose et al., 1999). Tcf1-/- mice develop adenomas in the gut and the
mammary glands. Introducing a mutant APC allele increased the number of
tumors and decreased the time of onset substantially. These findings indicate
that Tcf1 acts as a feedback repressor of b-catenin/Tcf4 target genes
suppressing malignant transformation of epithelial cells.
Deregulation of Wnt-signaling and cancer
Wnt-1 was first identified in mammary tumors in mice, indicating that
Wnt-signaling plays a role in tumor development. Wnt is not the only possible
component of the pathway, which can cause cellular transformation. APC is
mutated in 80% of all colon carcinomas (Polakis et al., 1999). Mutations
usually lead to truncation of APC, which is then no longer able to bind b-
catenin. As a consequence, cytosolic b-catenin is not phosphorylated and
accumulates. In colon tumors with wild type APC, the b-catenin (CTNNB1) gene
was examined for the presence of mutations. In 50% of these sporadic colon
tumors lacking APC mutations, mutations were indeed found in the CTNNB1
gene. These mutations occur in or around the third exon, which encodes the
putative phosphorylation sites of GSK-3b, removing the target residues of GSK-
3b (Morin et al., 1997; Polakis et al., 1999). Mutations in Axin have also been
found to contribute to the pathogenesis of colon tumors and other types of
malignancies (Webster et al., 2000). These findings suggest that the initiation
of colon cancer can almost exclusively be explained by deregulated Wnt-
signaling.
Mutations in b-catenin are not only found in intestinal tumors. The
CTNNB1 gene has been sequenced extensively in various other tumors. An
overview of the mutations found in b-catenin can be found at the Wnt-signaling
website (www.ana.ed.ac.uk/rnusse/pathways/bcatmut.html). The detailed
molecular understanding of the Wnt-signaling cascade now allows the search
for drugs that selectively target specific steps of the pathway. Structures of the
b-catenin/Tcf3 and b-catenin/E-cadherin complexes have recently been
elucidated (Graham et al., 2000; Huber and Weis, 2001). Birchmeier and
colleagues have performed an extensive mutational analysis of the basic
groove in b-catenin that binds Tcf, E-cadherin, APC and axin (von Kries et al.,
2000). This study revealed unique hotspots in the groove for each of these four
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interaction partners. This has raised hopes that unique inhibitors can be
designed for the b-catenin/Tcf interaction. Such inhibitors may constitute highly
precise drugs for colorectal cancer.
The biology of intestinal crypt cells
The epithelium of the intestine comprises alternating crypts and villi (Potten
and Loeffler, 1990). In the crypts the stem cell population is located from
which proliferating cells slowly migrate up toward the villus. These cells
differentiate into various distinct cell types. Once reaching the apex of the
villus, the cells die and are shed into the gut lumen. As discussed before, Tcf4
is expressed in the intestinal epithelium and the mammary glands. Tcf4 is
required for maintaining the stem cell compartment of the intestine (Korinek et
al., 1998). These data suggest that Tcf4 may be activated in the crypts due to
Wnt secreted from neighboring mesenchymal cells. It is, however, currently not
known if and which Wnt’s and Frz’s are expressed in the adult intestine.
Heterozygous ApcD718 knockout mice develop intestinal adenomas at a high
frequency (Oshima et al., 1995; Oshima et al., 1997). Abnormal outpocketing
of the intestinal epithelium at the crypt-villus border is the first sign of polyp
formation. This pocket protrudes into the inside of the neighboring villus,
subsequently filling the total space. The normal epithelium of this adjacent
villus remains normal and covers the polyp totally, even when several villi are
filled. Consequently the polyp is not exposed to the lumen of the gut. Polyps
are polyclonal, which is thought to be obligatory for tumor progression (Merritt
et al., 1997). During the earlier stages of polyp formation the proliferation rate
is not increased. The data obtained with this APC mutant are similar to the
sequence of events observed in mice overexpressing the N-terminally
truncated isoform of b-catenin (Harada et al., 1999). APC loss and the
subsequent stabilization of b-catenin results in an increase in size of the
proliferative compartment in the crypt region. A consequence is an altered
architecture of the intestine. As Tcf4 expression is required for crypt
maintenance, it is likely that inappropriate Tcf4/b-catenin signaling is
responsible for this phenomenon. Cells that normally would start to
differentiate when migrating up the crypt-villus axis, now are kept in a
proliferative and non-differentiated state, in other words, they remain crypt
cells. This is supported by the fact that b-catenin has been observed to supress
differentiation (Harada et al., 1999). For the polyps to progress to malignant
and invasive cancers, more mutations need to be gained, as reviewed
previously (Kinzler and Vogelstein, 1996). Why the loss of APC uniquely results
in tumor formation in the intestine, is unclear at present.
Though much is known about the Wnt signaling pathway and its involvement in
development and tumor formation, still many questions remain to be
addressed in the future. The mechanisms of the protein-protein interactions for
instance will provide alternatives to interfere, when the Wnt signaling cascade
is over active. In the last years  many proteins have been shown to influence b-
catenin/Tcf mediated signaling. The exact function of these proteins needs to
be resolved.
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Outline of this thesis
The making of a highly specific antibody against this non-phosphorylated form
is described as well as a thorough characterization of this antibody. This
antibody proved to be a useful tool to study the presence of active b-catenin in
tissue sections (Chapter 2). This tool was also used to prove a widely held
belief, that Wnt signals induce dephosphorylation of â-catenin and that
phosphorylation of b-catenin precedes ubiquitination. We could show with the
áABC antibody that in mouse development the antibody stained organ systems
which are impaired in their development in Tcf-4 and Lef-1 knock out mice. In
this thesis the necessity of non-phosphorylated b-catenin to mediate Wnt
signals to the nucleus is determined in Chapter 3. In Chapter 4 the áABC
antibody is used to investigate the role of signaling active b-catenin in breast
tumors. In 70% of these tumors nuclear presence of b-catenin in its non-
phosphorylated form is detected. In Chapter 5 we focus on the mechanisms of
b-catenin phosphorylation by GSK-3b. In order to accumulate b-catenin, it
needs to be synthesized de novo and the presence of a phosphatase which
constitutively dephosphorylates b-catenin seems very unlikely. The
phosphorylation of b-catenin is not unprimed as suggested in the literature and
the relative order of phosphorylation is determined. In the N-terminus of b-
catenin two additional serines are described, which are phosphorylated by
GSK-3b (Chapter 6). Mutations in these serines, however, do not result in
constitutively active b-catenin. The function of these serines therefore remains
unresolved.
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Abstract
At the heart of the canonical Wnt signaling cascade, APC, axin and GSK3
constitute the so called destruction complex which controls the stability of b-
catenin. It is generally believed that four conserved Ser/Thr residues in the N-
terminus of b-catenin are the pivotal targets for the constitutively active serine
kinase GSK3. In cells that do not receive Wnt signals, GSK is presumed to
phosphorylate b-catenin, thus marking the latter for proteasomal degradation.
Wnt signaling inhibits GSK3 activity. As a consequence, b-catenin would no
longer be phosphorylated and accumulate to form nuclear complexes with
TCF/LEF factors. Although mutations in or near the N-terminal Ser/Thr residues
stabilize b-catenin in several types of cancer, the hypothesis that Wnt signaling
controls phosphorylation of these residues remains unproven. We have
generated a monoclonal antibody, which recognizes an epitope containing two
of the four residues when both are not phosphorylated. The epitope is
generated upon Wnt signaling as well as upon pharmacological inhibition of
GSK3 by lithium, providing formal proof for the regulated phosphorylation of
the Ser/Thr residues of b-catenin by Wnt signaling. Immunohistochemical
analysis of mouse embryos utilizing the antibody visualizes sites that transduce
Wnt signals through the canonical Wnt cascade.
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Introduction
Wnt signal transduction controls multiple developmental events throughout the
animal kingdom. Wnt/wingless proteins constitute a large family (> 19
members in human) of secreted cysteine-rich glycoproteins. Wnts function as
ligands for a receptor complex consisting of one of several members of the
Frizzled (Fz) family of serpentine receptors 1 and of LRP-5/6, homologues of
the LDL receptor 2-4.
b-catenin participates in a large cytoplasmic protein complex, containing the
serine/threonine protein kinase glycogen synthase kinase-3 (GSK-3), the tumor
suppressor gene product APC (adenomatous polyposis coli) and axin/conductin
5-8. In the absence of Wnt, GSK-3 9;10 is constitutively active, and is believed to
promote degradation of b-catenin by N-terminal phosphorylation and
subsequent ubiquitination and proteasomal targeting 11;12. In response to Wnt,
the activity of GSK-3 is inhibited by an incompletely understood mechanism. As
a consequence, b-catenin’s breakdown is suppressed 13. Indeed, oncogenic
mutations in b-catenin at putative GSK-3 phosphorylation sites stabilize b-
catenin in colorectal cancer and melanoma 14, causing aberrant activation of
TCF 14;15. Interspecies sequence comparison of b-catenin as well as the
oncogenic point mutations in b-catenin have implied four N-terminal residues
as the targets of upstream kinases: Ser33, Ser37, Thr41 and Ser45 (for an
overview: see URL www.ana.ed.ac.uk/rnusse/pathway/bcatmut.html). To date
however, no biochemical data exist to confirm the regulated phosphorylation of
these residues. Such analyses are complicated by the fact that two separate
pools of b-catenin co-exist in epithelial cells. Independent of the pool of labile,
APC-bound b-catenin, a much larger, highly stabile pool of b-catenin is tightly
bound to the cytoplasmic tail of cadherin-type adhesion molecules. This second
pool effectively links cadherins to the actin cytoskeleton 16-18.
To provide formal biochemical proof for the regulated phosphorylation
of b-catenin during Wnt signaling, we have developed a monoclonal antibody,
aABC (a-active b-catenin), which recognizes non-phosphorylated Ser37 and
Thr41. We show that the antibody visualizes the generation of active b-catenin
by the canonical Wnt pathway during murine embryogenesis.
Materials and Methods
Cell lines and reagents
The 293T cell line was cultured in RPMI, complemented with 10 % fetal calf serum, penicillin and
streptomycin. ALLN (N-acetyl-Leu-Leu-norleucinal) was obtained from Sigma, LiCl from Riedel de
Haen.
Generation of an a-active b-catenin (aABC) antibody
A 300 bp PCR product encoding the first 100 amino acids of human b-catenin protein was cloned into
pET21a prokaryote expression vector [Novagen] and used to generate His-tagged recombinant
protein in BL21 E. coli. Six week old BALB/c mice were immunized with 200 mg of purified b-catenin(1-
100) fusion protein in Freund’s complete adjuvant [Difco], with a second injection in Freund’s
incomplete adjuvant [Difco] 14 days later. Following sacrifice of immunized mouse, the splenocytes
were fused to SP2/0 mouse myeloma cells using polyethylene glycol. The fused cell population was
resuspended in hypoxanthine aminotropterin thymidine selection medium [Life] and plated into 96-
well flat bottom culture plates. Hybridoma supernatants were screened by immunochemical staining
of methanol-fixed COS cells transfected with human b-catenin.
The â-catenin N-terminal deletion contructs were generated in pCDNA3neo [Invitrogen] by
polymerase chain reaction (PCR) and subcloned in the pGEM-T vector [Promega]. The following
primers were used:
WTmyc 5’: CCA AGG ATC CAC CAT GGA GCA GAA GCT GAT CAG CGA GGA GGA CCT GAT GGC TAC
TCA AGC TGA TTT G, D26 5’: CCA AGG ATC CAC CAT GGA GCA GAA GCT GAT CAG CGA GGA GGA CCT
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GCA ACA GTC TTA CCA CCT GGA CTC T, D31 5’: CCA AGG ATC CAC CAT GGA GCA GAA GCT GAT CAG
CGA GGA GGA CCT GGA CTC TGG AAT CCA TTC TGG T, D35 5’: CCA AGG ATC CAC CAT GGA GCA GAA
GCT GAT CAG CGA GGA GGA CCT GCA TTC TGG TGC CAC TAC CAC A, D39 5’: CCA AGG ATC ACC ATG
GAG CAG AAG CTG ATC AGC GAG GAG GAC CTG ACT ACC ACA GCT CCT TCT CTG, D43 5’: CCA AGG
ATC CAC CAT GGA GCA GAA GCT GAT CAG CGA GGA GGA CCT GCC TTC TCT GAG TGG TAA AGG C,
D48 5’: CCA AGG ATC CAC CAT GGA GCA GAA GCT GAT CAG CGA GGA GGA CCT GAA AGG CAA TCC
TGA GGA AGA G, D60 5’: CCA AGG ATC CAC CAT GGA GCA GAA GCT GAT CAG CGA GGA GGA CCT
GCA AGT CCT GTA TGA GTG GGA A, D 3’: CGG TTG CCT CGA GTC ATT GCA TAC TGT CCA TC. The
construction of pCIneo-S33Y-b-catenin and pCIneo-D45 b-catenin, encoding a b-catenin molecule with
an S to Y substitution or a deletion of amino acid S45, was described previously 14. 106 Cos cells were
transfected with 1 mg of the b-catenin constructs using DEAE Dextran and fixed in methanol after 2
days. After rinsing the plates, the cells were incubated with the supernatants of the hybridomas for 60
min, followed by the peroxidase labeled Rabbit-a-Mouse 1:100 [DAKO] for 30 min and AEC/H 2O2.
Pepscan analyses were performed by Pepscan BV., Lelystad, The Netherlands
Peptide ELISA
Covalink ELISA plates [Nunc] were activated by incubating with 100 ml 10 mM SPDP (3-(2-
pyridyldithio)propionic acid N-hydroxysuccinimide ester) [Sigma] in PBS for 30 min at 37°C. The
peptides used, were S33P: CQQSYLD S(-P) GIHSG, S37P: CLDSGIH S(-P) AGTTT and T41P: CIHSGAT
T(-P) TAPSL. 10 mM peptides in 0.1 M Tris-HCl, pH 8.0 were directly coupled to the bivalent linker via
the N-terminal cystein residue for 60 min at 37 °C. The coated plates were blocked with PBS/0.25%
BSA during 15 min. The monoclonal antibodies were allowed to bind for 45 min at 37 °C followed by
the secondary antibody Rabbit a-Mouse peroxidase labelled [DAKO] for 30 min at 37 °C. The staining
was visualized by adding ABTS (2’,2’-Azino-Bis(3-Ethylbenzthiazoline-6- Sulphonic Acid)
Diammonium, Boehringer)/H 2O2 and measuring the absorbance at 405 nm.
Western Blots
For detection of endogenous b-catenin protein, 106 sample cells were directly lysed in 200 ml of hot 2X
SDS-PAGE sample buffer (15 mM 1 M Tris pH6.8, 5% SDS, 40% Glycerol, 0.005% BPB, 8% b-MeOH),
vortexed vigorously, denatured by heating at 98 oC for 5 min, and cleared by centrifugation for 5 min
at 21,000 g. 20 ml of protein extract was resolved on a 10% (w/v) denaturing polyacrylamide gel, and
transferred to PVDF membrane [Immobilon-P, Millipore]. b-catenin protein was detected by probing
the blot first with aABC or a commercially available (pan) a-b-catenin antibody [Transduction
Laboratories, clone 14] followed by a horse-radish- peroxidase-conjugated rabbit anti-mouse IgG
polyclonal antibody [Pierce], and finally visualized by enhanced chemiluminescence [Amersham].
Immunohistochemistry
Mouse embryos were harvested between time points E10.5 and E16.5 days, and fixed in formalin at
4°C. They were subsequently embedded in paraffin and sectioned at 5 mm thickness. After de-
paraffination, endogenous peroxidase activity was blocked by incubating the sections in 1.5%
peroxide in methanol for 20 minutes. The sections were then boiled in 0.01 mol/L citrate buffer, pH
6.0, for 20 minutes and cooled slowly. Before staining, the sections were blocked with Rodent Block
[Labvision] for 60 minutes. The sections were washed in phosphate buffered saline (PBS) and
incubated with hybridoma culture supernatant of aABC or with the TL pan- b-catenin antibody
[Transduction Laboratories Inc.] diluted 1:100 in culture medium for 60 minutes. The sections were
washed in PBS and the primary antibody was detected with Poly-HRP-goat-a-mouse IgG
[Immunovision] and DAB solution.
Results and Discussion
Generating the dephospho-specific aABC antibody
To generate a monoclonal antibody against dephosphorylated b-catenin,
recombinant protein consisting of the N-terminal 100 amino acids of b-catenin
was produced in E. coli and used for mouse immunizations. In two fusion
experiments, a total of 16 hybridomas were isolated that recognized full-length
human b-catenin when overexpressed in COS cells (Fig 1A). To map the
epitopes recognized by these relevant monoclonal antibodies, we made a series
of myc-tagged N-terminal deletion constructs (D26, D31, D35, D39, D43, D48
and D62; numbered for the first amino acid of b-catenin to be expressed).
These constructs were transfected into COS cells. Immunohistochemical
stainings revealed that 2 hybridomas recognized epitopes coinciding with the
___________________________________ Wnts control â-catenin phosphorylation
33
region harboring the regulatory Ser/Thr residues (data not shown). This region
comprises the potentially phosphorylated residues Ser33, Ser37, Thr41 and
Ser45. Pepscan analysis was independently performed utilizing sequentially
overlapping 12-mer peptides covering aminoacid 1 to 52 of b-catenin. This
allowed the precise mapping of the epitopes recognized by all 16 antibodies.
The Pepscan data of the antibody 8E7, pertinent to this study, are depicted in
Fig 1B. The minimal epitope of the antibody as determined by PEPScan
comprised HSGATTTAP (residues 36 to 44). The epitope identity was confirmed
by transfecting Cos cells with expression constructs encoding several point
mutants of b-catenin. The antibody neither bound the S37A mutant, nor the
T41D mutant of b-catenin. Aminoacid substitutions at position S33 or S45 had
no effect on antibody binding (Fig. 2). Next, a phospho-peptide ELISA was used
to evaluate the influence of individual phosphorylation of the four Ser/Thr
residues on antibody recognition. Interestingly, a phosphate group at either
Ser37 or Thr41 prevented the binding of this monoclonal antibody to its
epitope (Fig. 1C).
Figure 1. Characterization of the aABC epitope. A) The N-terminal sequence of b-catenin, amino
acids 14 to 50 is depicted. The black boxes indicate the minimal binding epitopes of individual
monoclonal antibodies named below each box. as determined by Pepscan analysis. B) The Pepscan
analysis for the antibody 8E7 (renamed aABC), is given as an example. From the overlapping
sequences of the bound peptides the minimal epitope of the antibody was deduced to be H36-A43
encompassing the putative GSK targets, S37 and T41. C) Phosphorylation of either S37 (“S37P”) or
T41 (“T41P”) abrogated binding of aABC (8E7), but the epitope was restored upon dephosphorylation
by CIP treatment. S33P, a phosphorylated peptide not spanning the aABC epitope, was used as a
negative control.
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Upon dephosphorylation of the phosphorylated peptides with calf intestine
phosphatase the binding was restored. We tentatively named the antibody
“anti-active b-catenin (aABC)” and concluded that it recognizes an epitope
containing Ser37 and Thr41 residues only when both are dephosphorylated.
Figure 2. Confirmation of
the aABC epitope by
immunohisto-chemical
analysis of b-catenin
point mutants. Cos cells
were transfected with b-
catenin cons- tructs with the
indicated point mutations.
The pan- b-catenin TL
antibody stained all
mutants. The aABC epitope
was destroyed by point
mutants in S37 or T41.
Wnt signaling controls the phosphorylation status of the N-terminal
regulatory residues of b-catenin
We then sought to address whether Wnt signaling could generate the aABC
epitope. The accumulation of b-catenin levels was provoked in four different
ways in 293T cells. Wnt-1 was transiently transfected into these cells,
presumably activating Wnt signaling in an autocrine as well as a paracrine
fashion. As a positive control, cells were transfected with a b-catenin construct
encoding a dominant-positive mutant of b-catenin (D45-b-catenin), i.e. lacking
one of the critical regulatory residues 14. Two different pharmacological
treatments have been described to stabilize b-catenin. LiCl is presumed to
mimick Wnt-signaling by the inhibition of GSK3 activity 19. LiCl is predicted to
lead to the accumulation of non-phosphorylated, non-ubiquitinated b-catenin.
The proteasomal inhibitor peptide ALLN is predicted to induce the accumulation
of phosphorylated, ubiquitinated b-catenin 12. 293T cells were treated for 6 hrs
with these inhibitors. All samples were analyzed by Western blotting, stained
with either the C-terminal pan-b-catenin antibody (TL) or with aABC. The pan-
b-catenin antibody showed an increase in b-catenin levels under all conditions
(Fig. 3, top panel). Notably, treatment of the cells with ALLN led to an increase
in overall b-catenin levels, due to the appearance of higher molecular weight,
ubiquitinated forms of b-catenin. The aABC antibody showed similarly increased
levels of dephosphorylated b-catenin upon addition of Wnt-1, D45-b-catenin
and LiCl. However, no increase of the aABC signal was observed upon addition
of ALLN (Fig. 3, bottom panel). This indicated that the increased signal
obtained with the other stimuli was not merely a result of quantitative affinity
differences. Rather, the aABC antibody unequivocally visualized the presence of
b-catenin that is not modified at the regulatory residues S37 and T41.
Moreover, the ubiquitinated bands that appeared upon ALLN treatment did not
stain with the aABC antibody. This proved the notion that phosphorylation of b-
catenin precedes ubiquitination.
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Figure 3. Wnt signaling generates the dephosphorylated aABC epitope. 293T cells were
transfected with the indicated cDNAs, or treated with pharmacological inhibitors. Subsequently the
cells were analyzed by Western Blotting with either the TL (top panel) or the aABC antibody (bottom
panel). Mock: mock transfected. D 45: transfected with the activated b-catenin D45 mutant 25. LiCl:
treatment with 20 mM LiCl for 6 hours. Wnt-1: cells were transfected with Wnt-1 cDNA and cultured
for 24 hours. ALLN: cells treated with the proteasome inhibitor ALLN for 6 hours at 1ìM. All four
treatments moderately increased overall levels of b-catenin as demonstrated with the TL antibody
(top panel). Notably ALLN treatment induced the appearance of higher molecular weight, poly-
ubiquitinated forms. Bottom panel: analysis with the aABC antibody revealed strong induction of
dephosphorylated b-catenin upon transfection with D45 or Wnt-1 and LiCl treatment. ALLN treatment
led to a very moderate increase in dephosphorylated b-catenin, if at all. Importantly the
polyubiquitinated forms of b-catenin did not stain with aABC.
To confirm that the N-terminal modification of b-catenin indeed represented a
phosphorylation event, we performed the following experiment. 293T cells were
treated with LiCl or ALLN for 6 hrs, after which the samples were split. Half of
the samples were incubated with calf intestine phosphatase. Subsequently,
Western blotting was performed with the TL or aABC antibody. Significantly,
the signal detected by the aABC antibody, but not the TL antibody, increased in
the untreated control sample upon dephoshophorylated with CIP (Fig.4 lanes 1
and 4). In addition, the ALLN treated cells not only showed a specific increase
of aABC signal upon dephosphorylation, but a higher, presumably ubiquitinated
band appeared upon CIP treatment (lanes 3 and 6). The aABC signal from LiCl-
treated samples were much less affected by CIP treatment, in concordance
with the notion that LiCl should itself lead to an accumulation of non-
phosphorylated b-catenin (lanes 2 and 5). Taken together, these experiments
provide formal proof that Wnt signaling induces the accumulation of b-catenin,
not phosphorylated at the N-terminal regulatory residues S37 and T41.
Figure 4. Dephosphorylation of cellular â-
catenin generates the aABC epitope .
Lysates of 293T cells, either mock treated or
treated with LiCl or ALLN, were
dephosphorylated with CIP (+CIP) or not
further modified (-CIP). Top panel: no changes
in total b-catenin levels are observed upon CIP
treatment after analysis with the TL antibody.
Bottom panel: CIP treatment of the lysates
enhanced the expression of the aABC epitope in
the untreated or ALLN treated cells (arrow
heads). Notably dephosphorylation led to the
generation of the aABC epitope in poly-
ubiquitinated b-catenin (filled arrow head).
Effects on the LiCl treated cells were marginal,
presumably because b-catenin pool remains
largely unphosphorylated upon LiCl treatment.
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Visualization of activated b-catenin during embryonic development
To further demonstrate the physiological function of b-catenin phosphorylation
we examined the generation of S37/T41-dephosphorylated b-catenin at defined
sites during murine embryonic development. Our insights into the role of the
canonical Wnt cascade during mammalian development stem largely from
phenotypic analyses of transgenic/knockout mouse models in which expression
of various components of the cascade is manipulated. The canonical Wnt
cascade activated by Wnt/Fz interactions involves the destruction complex, b-
catenin and TCF. However, Wnt/Fz interactions can activate other parallel
signaling pathways. In insects, Wnt signaling activates the planar polarity
pathway which deviates downstream of Dishevelled to a MAP kinase cascade 20.
No vertebrate counterpart of this pathway has been described as yet. Moon
and colleagues have described a vertebrate Wnt/Fz-activated pathway that
involves protein kinase C and Ca++ mobilization 21;22. Genetic analyses of Wnt
and Fz genes by gene disruption have generally yielded dramatic phenotypic
abnormalities, yet do not reveal which downstream pathway is involved.
Genetic manipulations of genes encoding downstream components of the
canonical pathway, such as the TCFs, do provide such insights.
Previous studies in Tcf4-/- mice have indicated that the formation of the
crypt progenitor compartment in the small intestine is fully dependent on the
presence of Tcf-4. While the transition of intestinal endoderm into epithelium
proceeds normally in the absence of Tcf-4, no proliferative compartments are
maintained in the prospective crypt regions of the small intestine 23. Thus, an
epithelium results which is completely composed of differentiated, non-
proliferating enterocytes and goblet cells. This phenotype indicates that a Wnt
signal, most likely emanating from sub-epithelial stromal cells, activates a
canonical Wnt cascade in crypt epithelial cells, culminating in the activation of
TCF target genes by b-catenin/Tcf4 complexes.
Since the Tcf-4 phenotype first becomes visible at E16.5, we analyzed
sections of E16.5 embryos by aABC staining, and compared these to sections
stained with the pan-b-catenin antibody (Fig. 5A). While the latter antibody
prominently stained the adhesion junctions of villus and crypt regions alike (left
panel), aABC staining was weaker and restricted to the cytoplasm and nuclei of
cells in the prospective crypts (right panel). This indicated that the canonical
Wnt pathway was activated specifically in the prospective crypt cells as
predicted, and validated aABC staining as a tool to visualize activity of the
canonical Wnt pathway. Gene disruption of another TCF family member, Lef-1,
affects the late embryonic development of several structures including teeth,
whiskers, hair, and mammary glands 24. In accordance with the activity of the
canonical Wnt pathway in these structures, active b-catenin could readily be
detected in the ectodermal parts of the prospective toothbuds on day 12.5
after gestation (Fig. 5B). The same held for the follicles of the whiskers (from
day 13.5 onward, Fig. 5C) and the ectodermal sites of mammary gland
formation (day 16.5, Fig. 5D).
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Figure 5. Activity of the canonical
Wnt pathway during murine
embryonic development as
demonstrated with the aABC
antibody.  Paraffin sections of mouse
embryos were stained with either the
pan-b-catenin TL antibody (left panels) or
aABC (right panels). A) The intestine of a
day E16.5 mouse embryo shows high
levels of b-catenin in the adherens
junctions of all cells (left). The aABC
staining reveals the accumulation of
nonphosphorylated b-catenin in cytoplasm
and particularly in the nuclei of epithelial
cells in the prospective crypt region
(arrows). B) The tooth-buds at day E12,5
clearly showed the presence of active b-
catenin in the ectodermal compartment of
the toothbud (right), C) as well as the
developing whiskers (day 13,5), and D)
the mammary glands (day 16,5).
In this study, we provide formal evidence for the notion that, in the absence of
Wnt signaling, the N-terminus of b-catenin is phosphorylated prior to its
ubiquitination and degradation. Furthermore, we show that Wnt signaling as
well as the inhibition of GSK3 lead to the accumulation of dephosphorylated b-
catenin. We specifically demonstrate these phosphorylation events with the use
of a novel monoclonal antibody, which recognizes an epitope containing two of
the four proposed regulatory residues in b-catenin when both are non-
phosphorylated. Furthermore, we demonstrate that the antibody visualizes
sites that transduce Wnt signals through the canonical Wnt cascade during
embryogenesis. Since Wnt/Fz interactions have been demonstrated to activate
several different signal transduction cascades, the antibody may be
instrumental in outlining those signaling events that activate the canonical
pathway.
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Abstract
b-catenin mediates Wnt signaling by acting as the essential co-activator for TCF
transcription factors. Wnt signaling increases the half-life and therefore the
absolute level of b-catenin in responding cells. The current model states that
these changes in b-catenin stability set the threshold for Wnt signaling.
However, we find that pharmacological inhibition of proteasome activity by
ALLN leads to accumulation of cytosolic b-catenin, but not to increased TCF-
mediated transcription. In addition, in temperature-sensitive ubiquitination
mutant CHO-cells inhibition of ubiquitination increases b-catenin levels but does
not induce transcriptional activation of TCF reporter genes. Using an antibody
specific for b-catenin dephosphorylated at residues Ser37 and Thr41, we show
that Wnt signals specifically increase the levels of dephosphorylated b-catenin,
while ALLN does not. We conclude that changes in the phosphorylation status
of the N-terminus of b-catenin occurring upon Wnt signaling independently
affect the signaling properties and half-life of b-catenin. Hence, Wnt signals are
transduced via N-terminally dephosphorylated b-catenin.
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Introduction
Wnt genes encode a large family of secreted glycoproteins that modulate
developmental processes through interaction with Frizzled receptors and
subsequent activation of intracellular signal transduction pathways. The Wnt1
orthologue in Drosophila is Wingless (wg), a segment polarity gene product
that constitutes the first component of the Wingless signaling pathway (Nusse,
et al. 1991; Nusse and Varmus, 1992). A central effector of the Wingless/Wnt
pathway is â-catenin/Armadillo, a multifunctional 92 kD protein involved also in
cell adhesion (Miller and Moon, 1996). Some years ago, studies have provided
evidence that members of the TCF/Lef family of DNA binding factors bind with
â-catenin/Armadillo to form the ultimate downstream effectors (Brunner, et al.
1997; Molenaar, et al. 1996; Riese, et al. 1997; van de Wetering, et al. 1997;
Beherens, et al 1996) of this pathway. The emerging theme from these
examples is that â-catenin/armadillo interacts with a member of the TCF family
to form a bipartite transcription factor complex where TCFs mediate DNA
binding and â-catenin the transactivation domain.
In the Wnt/wg pathway, suppression of b-catenin degradation has been
proposed as the key signaling event (Miller and Moon, 1996). In the absence of
wg/Wnt, the serine/threonine protein kinase zeste white 3, or its vertebrate
homologue glycogen synthase kinase-3b (GSK-3b) (Yost, et al. 1996; Young, et
al. 1998) is active, and promotes degradation by N-terminal phosphorylation
and subsequent ubiquitination and proteasome targeting (Peifer, et al. 1994a).
In response to wg/Wnt, a cytoplasmic protein called dishevelled (dsh)
inactivates zw3/GSK-3b through largely unknown mechanisms, leading to
accumulation of b-catenin by suppressing its breakdown (Miller and Moon, R.
T., 1996). Indeed, oncogenic mutations in b-catenin in putative GSK-3b
phosphorylation sites stabilize b-catenin (Morin, et al. 1997).
In the cytoplasm, b-catenin participates in a large protein complex, containing
GSK-3â, the tumor suppressor gene product APC (adenomatous polyposis coli)
(Papkoff, et al. 1996), and axin (Hart, et al. 1998; Kishida, et al. 1998;
Sakanaka, et al. 1998) or its analog conductin (Behrens, et al. 1998) which
coordinately regulate the modifications of â-catenin which lead to
ubiquitination and proteasomal breakdown. The activity of the b-catenin
degradation complex may be regulated by phosphorylation of the components
APC, Axin and GSK-3b (Hart, et al. 1998; Kishida, et al. 1998; Sakanaka, et
al. 1998). The importance of regulation via this complex is illustrated by the
fact that mutations in APC or b-catenin that stabilize b-catenin in colon
epithelial cells, cause aberrant activation of TCF-4 leading to colorectal
tumorigenesis (Korinek, et al. 1997; Morin, et al. 1997), while mutations in
zw3 that stabilize Armadillo, mimic wg signaling (Peifer, et al. 1994b).
In the present study, we have investigated whether increases in b-catenin
levels are sufficient to activate the ultimate step in Wnt signaling, i.e. TCF-
dependent transcription. We provide two lines of evidence suggesting that the
increased half-life of b-catenin as a consequence of Wnt signaling is not directly
related to transduction of Wnt signals. We also show that Wnt-signals, in
contrast to pharmacological agents that inhibit b-catenin breakdown,
specifically increase the dephosphorylated form of b-catenin.
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Results
Current models of Wnt signaling state that Wnt signals inhibit the
phosphorylation of b-catenin, which results in accumulation of b-catenin and
that this accumulation is the key signaling event. However, oncogenic forms of
b-catenin all have mutations in putative GSK-3b phosphorylation sites.
1. Pharmacological inhibition of b-catenin breakdown
We first investigated if increasing the b-catenin half-life by pharmacological
reagents would influence TCF-dependent transcription. We made use of the
peptide aldehyde ALLN (Calpain inhibitor I), which inhibits proteasome-
mediated proteolysis and has been shown to dramatically increase cellular â-
catenin levels (Aberle, et al. 1997). Indeed treatment of 293T cells with ALLN
for up to 6 hours strongly increased b-catenin levels (Fig 1A). Surprisingly,
when 293T cells were transfected with TCF reporter constructs (termed TOP-
Flash and the mutant control FOP-Flash) and after overnight recovery were
treated with ALLN for 6 hours, we did not observe any increase in TCF-
mediated transcription (Fig 1B, left panels). Similar results were obtained with
C57MG, Rat-1 and Jurkat cells (data not shown).
Fig 1. Lack of
transactivation by
ALLN-induced increase
in b-catenin levels. 293T
cells were treated with the
proteasome inhibitor ALLN
for 6 hours and analysed
for b-catenin levels by
Western blotting. Equal
amounts of protein were
loaded in each lane. The
arrow indicates the
untreated b-catenin band.
In parallel, 293T were
transfected with TOP and
FOP reporter plasmids,
Renilla-Luciferase control
vectors and S33 b-
catenin. ALLN treatment
does not induce activation
of the reporter constructs,
despite accumulation of b-
catenin. Co-transfection of
S33 b-catenin can still
induce TCF-dependent
transcription under ALLN
treatment, indicating that
the cells are signaling
competent.
It could be that the cells are not signaling-competent because of the ALLN
treatment due to non-specific toxic effects of treatment. We therefore
investigated if ALLN treated cells are signaling competent. Co-transfection of
S33-b-catenin led to a strong increase in TCF-dependent transcription in both
ALLN-treated and non-treated 293T cells (Fig 1B, right panel), showing that
cells can activate TCF reporter genes under ALLN treatment. Similar results
were obtained with Rat-1 fibroblasts and Jurkat T cells (data not shown).
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2. Genetic experiments to increase b-catenin levels
b-catenin is phosphorylated, ubiquitinated and then degraded in the
proteasome (Orford, et al. 1997; Peifer, et al. 1994a). Thus, inhibition of
ubiquitination should also lead to increases in the amounts of cellular b-catenin.
The ts20 CHO cell line harbors a specific temperature-sensitive mutation in the
E1 ubiquitin conjugation enzyme and has been widely used in studies aimed at
understanding the role of ubiquitination in signaling pathways (Kulka, et al.
1988; Strous, et al. 1996; Strous, et al. 1997). When shifted from the
permissive temperature (30°C) to the restrictive temperature (40°C), these
cells fail to ubiquitinate b-catenin. Indeed, upon growing the cells at 40°C, b-
catenin levels increase (Fig 2A). The parental CHO cells (E36) did not show this
increase in b-catenin levels (not shown). We transfected these ts20 CHO cells
with the TCF reporter constructs TOP-Flash and FOP-Flash, control plasmids
and a TCF4 expression construct. Increasing b-catenin levels by inhibition of
ubiquitination at 40°, did not result in increased TCF-controlled transcription
(Fig 2B), similar to results obtained when b-catenin degradation was blocked by
inhibition of proteasome activity. Importantly, the cells incubated for 6 hours at
the restrictive temperature were still capable of activating TCF-dependent
transcription when co-transfected with S33 b-catenin (Fig 2B), indicating that
the lack of reporter gene activity was neither caused by toxic effects of
blocking the ubiquitination nor from shifting the temperature.
Fig. 2. Increased b-catenin
half-life by inhibition of
ubiquitination does not lead
to increased TCF-dependent
transcription. Ts20 cells were
incubated at the restrictive
temperature, 40 °C for 6 hours.
Subsequently the cells were
lysed and analyzed on Western
Blot using the TL a-b-catenin
antibody. ts20 cells were
transfected with reporter
constructs with or without S33
b-catenin and immediately
shifted to restricted
temperature (40 °) for 6 hours.
While b-catenin levels
increased (Fig 2A), TOP/FOP
ratios remained the same. In
addition, under conditions were
ubiquitination is inhibited, the
cells are still capable of
activating TCF-dependent
transcription, when transfected
with b-catenin.
3. Dephosphorylated b-catenin and Wnt signaling
The above data show that increased levels of b-catenin per se are not sufficient
to activate TCF mediated transcription. We therefore reasoned that
dephosphorylation of b-catenin could constitute an essential activating
modification induced by Wnt signals. We set out to generate an antibody
specific for the non-phosphorylated form of â-catenin to test this hypothesis.
This antibody called aABC was generated using the first 100 aa of the human
b-catenin sequence. The specificity of the antibody was established using
deletion constructs, the Pepscan method and a-phosphopeptide ELISA’s. The
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epitope of aABC was found to be HSGATTTAP (residues 36 to 44), thus
harbouring therefore dephosphorylated S37 and T41 (van Noort, unpublished
data). To investigate the role of dephosphorylated b-catenin in Wnt signaling,
we used four different treatments to increase b-catenin levels and
simultaneously detect its phosphorylation status and its transactivation
potential (Fig. 3). These treatments include transfection with S33 b-catenin,
wnt1 and incubations with LiCl or ALLN. LiCl is an inhibitor of GSK-3b activity
and is widely used to mimic Wnt-signaling. S33 b-catenin is a dominant-
positive mutant of b-catenin where S33 is mutated into a tyrosine. This serine
is not part of the epitope of aABC. The levels of b-catenin as detected with the
commercially available C-terminal pan-b-catenin antibody, were only slightly
increased upon transfection of S33 b-catenin and Wnt1 as well as after
treatment with LiCl (In some experiments total b-catenin levels increased
somewhat more, compare Fig 5). Treatment of the cells with ALLN resulted in
an increase in b-catenin levels with the typical pattern of multiple ubiquitinated
bands (Fig 3A). In contrast, probing the same lysates with the antibody specific
for dephosphorylated b-catenin showed dramatic differences. Transfection with
Wnt1 and treatment with LiCl drastically increased the levels of
dephosphorylated b-catenin. The S33 b-catenin transfection also showed a
striking increase in the amounts of dephosphorylated b-catenin, whereas these
levels did not alter upon ALLN treatment (Fig. 3B). In the same experiment,
these cells were used to investigate the induction of TCF-mediated transcription
(Fig. 3C). As expected, TOP/FOP activity was induced by transfection with S33
b-catenin (200 fold) and wnt1 (5 fold) as well as by treating the cells with LiCl
(230 fold). ALLN, however, failed to elevate the TOP/FOP ratio. Thus,
treatments that resulted in increased amounts of dephosphorylated b-catenin
all resulted in increased TCF dependent transcription.
Fig. 3. Levels of nonphosphorylated b-catenin correlate with the transcriptional activity.  A)
293T cells were transfected with S33 b-catenin, Wnt1 or treated with ALLN and LiCl. Cells were
analyzed by Western blot using an pan-anti-b-catenin antibody directed against the C-terminus. Equal
amounts of protein, as confirmed by Ponceau S staining, were loaded onto each lane. B) The same
samples as under A were analyzed by Western blot with an antibody directed against N-terminally
dephosphorylated b-catenin. Protein amounts (intensity of specific bands) were measured by
densitometry. Wnt: 2 fold increase over untreated cells, Lithium and S33 b-catenin: 10 fold, ALLN no
change. C) Parallel samples of the conditions under A and B, were transfected with optimal (TOP) or
mutated (FOP) luciferase reporter plasmids and analyzed for TCF-dependent transcription by
measuring luciferase activity. Shown is the ratio of the specific versus control signals (corrected for
transfection efficiencies) termed TOP/FOP.
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Subsequently, we confirmed these data in ts20 CHO cells (Fig. 4). As shown in
figure 2A, extracts from cells incubated at the restrictive temperature show
increased levels of b-catenin. The levels of dephosphorylated b-catenin, as
visulaized by aABC antibody, however, remained low, corroborating that an
increase in dephosphorylated b-catenin, but not in phosphorylated/
ubiquitinated b-catenin, is required for TCF-mediated signaling.
Fig. 4. Ts20 CHO cells fail to
show increased levels of
dephosphorylated b-catenin.
The Ts20 CHO cells were kept at
the restrictive temperature for 6
hours, before they were
analyzed on a Western blot for
their levels of dephosphorylated
b-catenin, as well as for total b-
catenin levels. Whereas total b-
catenin levels increase,
dephosphorylated levels remain
low.
Surprisingly, the increase in TCF mediated transcription for transfection with
S33 b-catenin and LiCl treatment is far greater (>200 fold) than the increase in
the active form of b-catenin (~ 10 fold), as was shown in Figure 3. For Wnt1
transfection, which results in a modest increase in the amounts of active b-
catenin (2 fold), the increase of TCF activity also is modest (5 fold). These
discrepancies could be accounted for by potential differences in cellular
localization of the activated form of b-catenin. We therefore investigated
localization of the total and dephosphorylated b-catenin pools by immuno-
fluorescence after LiCl treatment and Wnt transfection. Both treatments with
LiCl and Wnt1 transfection lead to increases in the total pools of b-catenin,
mostly in the cadherin-associated plasma membrane pool. Interestingly, most
of the dephosphorylated b-catenin is found in the nucleus, where it can interact
with Tcf, and far more dephosphorylated b-catenin is found in the nucleus after
LiCl treatment compared to Wnt1 transfection. This increased pool of nuclear b-
catenin available to interact with Tcf-1 and induce transcription, can explain the
much higher reporter gene activity after LiCl treatment (Fig. 5).
Discussion
Several studies have shown that b-catenin levels increase upon Wnt/wg
signaling (Miller and Moon, 1996; Yost, et al. 1996; Young, et al. 1998). Here
we have investigated if this increased half-life sets the threshold for signaling.
Using ALLN and ts20 cells we demonstrate that signaling by b-catenin/TCF is
not a direct consequence of the increased b-catenin half-life that occurs upon
Wnt signaling. Rather, they suggest that changes in the phosphorylation status
of the N-terminus of b-catenin that occur upon Wnt signaling independently
affect its signaling properties and its half-life. Using a monoclonal antibody
(aABC) directed against dephosphorylated b-catenin, we show that only bona
fide Wnt signals lead to an increase in unphosphorylated b-catenin.
We noticed that the increase in TCF-mediated transcription for LiCl treatment is
far greater than the increase in the active form of b-catenin, whereas Wnt1
transfection results in a modest increase in both the amounts of active b-
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catenin and TCF reporter gene activity. These discrepancies between Wnt1 and
LiCl could be accounted for by several reasons: First, there might be a
threshold in the amount of b-catenin required for transcription and the amount
of active b-catenin induced by Wnt1 may only just reach this threshold.
Second, since wnt1 operates more upstream in the pathway, its activity might
be subjected to negative regulators that are bypassed by LiCl. Third and most
importantly, the amounts of dephosphorylated b-catenin in the nucleus are
different between these two treatments (Fig 5), and therefore the pool of
signaling competent b-catenin that interacts with Tcf and induces transcription.
It is likely that LiCl inhibits GSK-3b more than Wnt1 transfection, raising the
possibility that the export of b-catenin from the nucleus could be impaired upon
LiCl treatment. Indications for this notion come from studies demonstrating
that GSK-3b is involved in the nuclear export of the transcription factor NF-AT
(Devereux, et al. 1999).In this context, it is of interest that the import of b-
catenin in the nucleus has recently been shown to constitute a regulated event
(Fagotto, et al. 1998). Possibly, regulated nuclear import of b-catenin is
dependent on its phosphorylation status and represents a key regulatory step
in the pathway.
Fig. 5. Strongly increased levels of nuclear dephosphorylated b-catenin after Wnt signaling.
293T cells were treated with LiCl or transfected with Wnt, cytospins were prepared and slides were
stained with an antibody specific for total b-catenin (top) or dephosphorylated b-catenin (bottom),
followed by a FITC-labeled secondary antibody. The levels of b-catenin increase in all cases compared
to mock-treated cells, but a dramatic increase in dephosphorylated b-catenin is seen with LiCl and to a
lesser extend with Wnt1.
The lack of induction of TCF-dependent transcription by the proteasome
inhibitor ALLN we observed, contrasts with reports by Easwaran et al.
(Easwaran, et al., 1999). These authors have used a different cell type with a
mutation in the APC gene and much longer (24 hour) incubations than we have
used (6 hours), perhaps allowing for secondary events (e.g., de novo synthesis
of b-catenin) to induce activation of the reporter gene. The reporter gene used
was different from ours in that it contains a long “minimal promoter”,
containing potential binding sites for other transcription factors, instead of
solely a TATA box, as in our reporter gene used. Collectively, this may explain
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the differences found between the two systems.
Support for our model of Wnt signaling comes from two studies by Gumbiners
group done in a cell free system based on early Xenopus embryos (Nelson and
Gumbiner, 1999; Guger and Gumbiner, 2000). These investigators show that
b-catenin derived from a pre-existing pool can be activated to signal and that
accumulation of this active form does not require ongoing synthesis. This
contrasts with the established model where b-catenin accumulates through
build up of newly synthesized protein (Peifer, et al. 1994b). We also find that
accumulation of b-catenin is insufficient for transmission of Wnt signals and
additionally show that the activation signal proposed by Nelson and Gumbiner
is represented by dephosphorylated b-catenin. The other report by Guger and
Gumbiner shows that mutations in the putative GSK-3â phosphorylation sites
of beta-catenin enhance its signaling activity, but that this cannot be accounted
for by accumulation of either total or cadherin-free protein. Again this
corroborates our conclusion that accumulation of b-catenin is insufficient for
signaling.
Several studies have reported that b-TrCP is a component of the ubiquitin
ligase complex which specifically interacts with phosphorylated â-catenin (Hart,
et al. 1999; Liu, et al. 1999). b-TrCP contains two important domains, the F-
box and the WD40 repeat region. The F-box interacts with the ubiquitin
complex, while the WD40 repeats mediate the interaction of the N-terminus of
â-catenin. In apparent contradiction to our results, the DF-box b-TrCP deletion
mutant (which still binds phosphorylated b-catenin), induces Tcf dependent
transcription (Hart, et al. 1999; Lui, et al. 1999). An explanation to reconcile
these apparently contradictory results may be found in the notion that the
deletion mutant will directly bind to phosphorylated aminoacid stretches, and
may thus neutralize the presence of the charged phosphate groups. Only in this
special case would phosphorylated b-catenin induce Tcf mediated transcription.
This hypothesis is supported by the fact that b-catenin lacking the complete N-
terminus is a potent transcriptional activator, because it can no longer bind to
b-TrCP and cannot contain negatively charged phosphate groups.
Additionally, it is possible that DF-box b-TrCP affects not only b-catenin but also
other proteins involved in Tcf controlled transcription. Experimental evidence
supporting this possibility stems from experiments in which mutants of b-TrCP2
are used. b-TrCP2 is incapable of interacting with b-catenin and is therefore not
involved in its degradation. As reported by Hart et al. the F-box mutant of b-
TrCP2 induces Tcf dependent transcription, apparently in a b-catenin
independent fashion (Hart, et al. 1999). b-TrCP could interact with the same
unidentified factor as b-TrCP2. Thus the effect of DF-box b-TrCP on Tcf
mediated transcription could be a composite of the direct effect on â-catenin,
on the unidentified factor and of the increase in dephosphorylated b-catenin.
Loss of function of the Drosophila b-Trcp homologue, Slmb, leads as expected
to high levels of Armadillo (arm), the fly b-catenin homologue (Jiang and
Struhl, 1998). If control mechanisms similar to those of b-catenin regulate Arm
transactivation, we would predict that wg target genes would not be induced in
Slmb mutant cells. However, the wg target gene Scute is induced in Slmb
mutants, suggesting that simple accumulation of Arm is sufficient for wg signal
transduction in flies. This is in contrast to our and Gumbiners findings in
vertebrate cells. Perhaps dephosphorylated arm can accumulate under these
conditions, or additional control mechanisms that modify TCF and b-catenin in
vertebrates are absent in Drosophila. It would be of interest to investigate the
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phosphorylation status of Arm capable of signaling with a similar antibody as
described here for b-catenin.
In summary, in contrast to widely held belief that accumulated b-catenin levels
are sufficient to transduce Wnt-signals, we demonstrate here that this is
mediated by N-terminally dephosphorylated b-catenin. Thus the accumulation
of b-catenin and transduction of Wnt signals are separable events, in that
effects on stability of b-catenin can be dissociated from its effects on signaling.
In a variety of tumors the putative GSK-3b phosphorylation sites are mutated,
which is regarded as a major oncogenic event in the pathogenesis of these
malignancies. Our data suggest that it is not the accumulation of b-catenin per
se, but the lack of phosphorylation of this increased pool of b-catenin, which is
the key oncogenic step.
Methods
Constructs, transfections and reporter gene assays
Expression constructs of b-catenin have been described (Molenaar et al., 1996). In some experiments
pCI-b-catenin, or pCI-S33-b-catenin constructs were used in stead of pCDNA constructs. The TK-TOP
and TK-FOP optimal and mutated TCF Luciferase-reporter constructs have been described (Staal et al,
1999). CHO cells were transfected using lipofectamine (GIBCO Brl), 293 T cells using FuGene-6
(Boehringer Mannheim). pSV40-CAT was used to normalize for transfection efficiency.. CAT and
luciferase values were determined as described (van de Wetering, et al. 1997). For the 293T cells
TOP-Glow and FOP-Glow were transfected, which are similar to TK-TOP and TK-FOP, except for a
TATA box instead of the TK minimal promoter. For 293T cells, 300 ng of the â-catenin constructs, 100
ng reporter, 20 ng CMV-Renilla, and, where appropriate, pCi to equilibrate the amount of plasmid DNA
transfected were used.
Cells and reagents
For ALLN treatment, cells were washed and treated for 6 hours with 10 ìM ALLN from a 1000x stock
prepared in ethanol. ts20 cells were shifted to the restrictive temperature of 40 °C for 6 hours or the
indicated amount of time, using MEMá medium containing a HEPES buffer. Cells were split in three
fractions, one for luciferase determination, one for CAT assay and one for western blotting.
Western Blots
10 6 cells were directly lysed in 200 ìl of boiling 2X SDS-PAGE sample buffer. Equal amounts of protein
were separated on a 10% polyacrylamide gel. b-catenin protein was detected by probing the blot first
with aABC or a commercially available a-b-catenin antibody [Transduction Laboratories, clone 14]
followed by a HRP-conjugated rabbit anti-mouse IgG antibody [Pierce], and visualized by enhanced
chemiluminescence [Amersham].
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Abstract
Wnt signaling plays an important role in normal development, but several of its
components also contribute to tumor formation. In the absence of Wnt-signals,
cells keep their b-catenin levels low by phosphorylation and subsequent
ubiquitination, which results in b-catenin degradation by the proteasome.
Recently, we have shown that accumulation of b-catenin per se is not sufficient
for signaling. Only N-terminally dephosphorylated b-catenin is able to
transduce Wnt signals to the nucleus. In tumors, mutations of b-catenin in its
putative phosphorylation sites and elevated levels of total b-catenin levels have
often been detected. Wnt1 was originally discovered as an oncogene in murine
breast tumors, while recent genetic evidence in mice has also implied APC and
Tcf-1 to be important in breast tumor formation. Therefore, we chose a panel
of breast tumors to investigate if we could detect elevated levels of  signaling-
competent b-catenin in tumor tissues with a highly specific antibody against the
non-phosphorylated form of b-catenin. We observed strongly increased levels
of dephosphorylated b-catenin in 60% of the tumors tested. No correlation was
observed between the presence of high levels of b-catenin and the type of
carcinoma, the differentiation grade, metastatic potentials or the levels of  the
adherens junction protein E-cadherin.
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Introduction
b-catenin was originally cloned as a component of the adhesion junction, a
structure mediating epithelial cell-cell adhesion. b-catenin links E-cadherin to a-
catenin and thereby bridges the cytoskeleton to the adherens junctions. It is E-
cadherin that forms a molecular zipper with other E-cadherin proteins via their
extra-cellular calcium-binding domains, to establish the cell-cell adhesion
(Ozawa et al., 1989; Cowin, 1994; Gumbiner, 1993). Loss of E-cadherin
expression or function has been implicated in tumor invasion and metastasis
(reviewed in Christofori and Semb, 1999).
Later, b-catenin was identified as being a key player in the Wnt-signaling
pathway and thereby being of importance for normal development but also for
tumor growth. Wnt factors are secreted cysteine-rich glycoproteins, which are
the ligands for members of the Frizzled family (Bhanot et al., 1996) and the co-
receptor LRP5/6 (Mao et al., 2001; Tamai et al., 2000; Wehrli et al., 2000). In
the canonical Wnt-signaling cascade, a cytoplasmic b-catenin pool independent
of the adherens junction pool, plays a central role. Its levels are regulated very
tightly. In cells devoid of Wnt-signals, b-catenin is complexed by axin-
conductin, APC, and the serine/threonine kinase GSK-3b. In this complex, b-
catenin is phosphorylated by GSK-3b at its N-terminus (Behrens et al., 1998;
Kishida et al., 1998; Ikeda et al., 1998). Phosphorylated b-catenin specifically
recruits b-TrCP. b-TrCP binds b-catenin with its WD40 repeats and interacts
with the ubiquitination machinery via its F-box (Feldman et al., 1997; Skowyra
et al., 1997). b-catenin is then labeled with multiple copies of ubiquitin
(Ciechanover, 1994), which targets the protein for rapid degradation by the
proteasome (Hart et al., 1999). In this way, b-catenin levels are kept low,
thereby preventing b-catenin to signal. Upon Wnt binding to its receptor, the
kinase activity of GSK-3b is inhibited. b-catenin is no longer phosphorylated
and degraded, it accumulates and translocates to the nucleus, where it
interacts with a member of the TCF/LEF family of transcription factors (Behrens
et al., 1996; Molenaar et al., 1996; Brunner et al., 1997; Riese et al., 1997;
van de Wetering et al., 1997). It is specifically the non-phosphorylated b-
catenin, which upon accumulation increases target gene transcription (Staal, in
press).
Recently, we generated a set of antibodies against the N-terminus of b-catenin.
This set was extensively characterized by Pepscan analysis and phosphopeptide
ELISA. One monoclonal, a-active b-catenin (aABC) was found to be specific for
S37 and T41 if non-phosphorylated, and thereby provided a tool to monitor the
signaling-competent form of b-catenin (van Noort et al., 2002).
The role of Wnt-signaling in many types of cancer is now undisputed. Wnt-1
was first cloned as Int-1 from MMTV-virus transformed mammary tumors in
mice (van Ooyen and Nusse, 1984). In Familiar Adenomatous Polyposis (FAP),
patients characteristically develop hundreds to thousands of colorectal tumors
due to inherited mutations in their APC gene (Groden et al., 1991; Nishisho et
al., 1991). Significantly, APC is also mutated in about 80% of sporadic forms of
colon carcinomas. These mutations mostly generate truncated proteins which
are no longer able to bind b-catenin, to promote its phosphorylation and
degradation. 15% of colorectal cancers are caused by mutations in the putative
GSK-3b phosphorylation sites in b-catenin’s N-terminus (Morin et al., 1997).
Mutations in APC as well as in b-catenin all result in stabilizing
dephosphorylated b-catenin. This interacts with TCF-4 to form constitutively
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active transcriptional complexes. Stabilized forms of b-catenin are believed to
being causative for instance for melanoma, desmoid tumors, Wilm’s tumors,
and tumors of bone and soft tissue (Rubinfeld et al., 1997; Alman et al., 1997;
Miyoshi et al., 1998; Koesters et al., 1999; Iwao et al., 1999).
To investigate the involvement of b-catenin/TCF mediated signaling in tumors,
the aABC antibody could represent a powerful tool. We therefore set out to
analyze if this antibody could be used on human (tumor) tissue, before staining
a panel of breast carcinomas. We chose breast carcinomas, as a percentage of
these tumors are likely to show involvement of hyperactive Wnt-signaling. Not
only was Wnt-1 cloned from murine mammary gland tumors, Tcf-1 was also
found to act as a tumor suppressor in mammary adenocarcinomas (Roose et
al., 1999).
Materials and Methods
Immunohistochemistry
Tissue samples were fixed in formalin, embedded in paraffin, and sectioned at 5 mm thickness.
Endogenous peroxidase activity was blocked by incubating the cells in 1.5% peroxide in methanol for
20 minutes. The slides were subsequently immersed in 0.01 mol/L citrate buffer, pH 6.0, boiled for 20
minutes and cooled slowly. Before staining the sections were blocked with Normal Goat Serum for 15
minutes. Slides were then incubated with culture supernatant of the aABC hybridoma or with a-E-
cadherin or TL pan- b-catenin diluted 1:250 in culture medium for 60 minutes. The primary antibody
was linked for 15 minutes by a biotinylated goat a-mouse, labeled for 15 minutes with HRP
conjungated streptavidin and visualized with DAB [Sigma].
Cell lines
All cell lines were cultured in RPMI, complemented with 10 % fetal calf serum, penicillin and
streptomycin.
Western Blots
For detection of endogenous b-catenin protein, 106 sample cells were directly lysed in 200 ml of hot 2X
SDS-PAGE sample buffer (15 mM 1 M Tris pH6.8, 5% SDS, 40% Glycerol, 0.005% BPB, 8% â-MeOH),
vortexed vigorously, denatured by heating at 98 oC for 5 min, and cleared by centrifugation for 5 min
at 21,000 g. The samples treated with calf intestine phosphatase were rinsed with PBS, sonicated in
PBS with protease inhibitors, prior to adding of the 10 units of calf intestine phosphatase for 5 min at
32 °C. 20 m l of protein extract was resolved on a 10% (w/v) denaturing polyacrylamide gel, and
transferred to PVDF membrane [Immobilon-P, Millipore]. â-catenin protein was detected by probing
the blot with aABC or a commercially available a-b-catenin antibody [Transduction Laboratories, clone
14] followed by a horse-radish- peroxidase-conjugated rabbit anti-mouse IgG polyclonal antibody
[Pierce], and finally visualized by enhanced chemiluminescence [Amersham].
Results and Discussion
Signaling-competent b-catenin is present in the crypts of the fetal
intestine
Disruption of the gene encoding Tcf-4 results in depletion of the epithelial stem
cell compartment in the crypts of the small intestine, indicating that Wnt-
signaling is active in the crypts of the intestine. Therefore, we studied whether
aABC is suitable for use on human paraffin embedded sections on fetal
intestinal tissues. Sections of small intestine (data not shown) and colon were
stained with the pan-b-catenin antibody (TL) and aABC (Fig. 1). The TL
antibody showed strong staining of the adherens junctions in crypt and villus
cells alike (Fig. 1A, B). In contrast, the aABC antibody only stained some nuclei
of the crypt cells but not the adherens junctions. With these data, we could not
only show that aABC could be used on paraffin-embedded human tissue, these
results also confirmed the hypothesis that Wnt-signaling is active in certain
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cells at the bottom of the crypt during development, presumably the stem cell
compartment.
Figure 1. aABC stains signaling-competent b-catenin in the crypts of human embryonic
colon. Human embryonic colon tissue was stained with the TL antibody and aABC. A) The TL
antibody, staining the total pool of b-catenin, is immunoreactive at the adherens junctions of the cells
in crypts and villi. B) The aABC antibody, however, only stains the cells in the crypts. The staining is
cytoplasmic and several cells show nuclear staining as well.
aABC reveals the presence of active b-catenin in colon carcinomas
As Wnt signaling accounts for ±95% of colorectal carcinomas, sections of these
tumors should exhibit the presence of signaling-competent b-catenin. To
investigate whether levels of b-catenin in tumors are high enough to be
detected by aABC, we stained a colon carcinoma sample and a polyp (Fig. 2).
The TL antibody showed strong staining of the tumor cells particularly of the
adherens junctions, making it difficult to observe nuclear staining (Fig. 2 A, B).
The aABC staining on the colon carcinoma section was strictly nuclear, whereas
in the polyp, it was cytoplasmic as well as nuclear. In other samples, the
adherens junctions occasionally stained weakly, but never as strong as the
staining with TL (data not shown). We concluded that aABC is therefore
suitable for localizing signaling-competent b-catenin in the nucleus.
Figure 2. Signaling competent b-catenin is not restricted to the crypts in colon polyps and
carcinoma. A) Samples of a human polyp and a colon carcinoma sample were stained for the total
pool of b-catenin and B) the presence of signaling-competent b-catenin. The polyp shows scattered
nuclei positive for active b-catenin, whereas the normal tissue is completely negative (arrow). The
carcinoma sample shows nuclear presence of aABC signal in all cells.
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70% of human  breast carcinomas are positive for  signaling-
competent b-catenin
The previous experiments showed that aABC could be a useful tool to
investigate the involvement of b-catenin/TCF mediated signaling in the
transformation process. As pointed out above, analyses in mice have implied
the Wnt cascade as a central player in the transformation of breast epithelium.
In stark contrast to these mouse studies, mutations in components of the Wnt
pathway such as APC are extremely rare in cell lines derived from human
breast cancer. We therefore studied human breast tumors for the presence of
an activated Wnt pathway in vivo. First we stained normal breast tissue with TL
and aABC antibody to establish b-catenin levels in non-transformed breast
tissue (Fig. 3). The TL antibody clearly stained adherens junctions, as expected
(Fig. 3, left panel). The aABC antibody, however, did not stain these normal
tubules (Fig. 3, right panel).
Figure 3. Normal breast tissue is negative for aABC. Paraffin sections of normal human breast
were stained with both b-catenin antibodies. Left panel: The TL antibody clearly stains the lateral cell
membrane, where b-catenin is present in the adherens junctions. Right panel: The aABC antibody,
however, does not stain these cells.
We then proceeded with the analysis of a panel of twenty mammary tumors.
We not only stained for the total amount of b-catenin and for the localization of
signaling competent b-catenin, but we also determined the presence of E-
cadherin. E-cadherin is often lost in breast carcinoma as a relatively late event
Van de Wetering et al. reported that the loss of E-cadherin in breast tumor cell
lines did not result in target gene expression as measured in reporter gene
assays (van de Wetering et al., 2001), whereas other studies reported
increased b-catenin levels upon loss of E-cadherin (reviewed by Behrens, 1999;
Iwao et al., 1998). An additional question we therefore wanted to address was
if E-cadherin levels correlate with the presence of dephosphorylated b-catenin
in the nucleus.
Table 1 shows a summary of the data collected on the 20 breast carcinoma
samples. Listed are the type of tumor, lobular or ductal, the differentiation
grade according to Bloom and Richardson (Bloom and Richardson, 1957), the
mitoses per area index (MAI) and the amount of affected lymph nodes. This
table shows clearly that no obvious correlation was found between the
presence of signaling-competent b-catenin in the nucleus, and either one of the
listed parameters. Examples of several tumors are depicted in figures 4 and 5.
Fig 4A shows a ductal tumor, which was grade II according to Bloom and
Richardson. This tumor was E-cadherin positive and contained nuclear levels of
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active b-catenin. Another example of a ductal type tumor lacked E-cadherin,
but was positive for aABC (Fig. 4B), whereas the tumor depicted in figure 4C
was negative for both E-cadherin and active b-catenin. This example was also
interesting because the TL antibody clearly showed that b-catenin was present
in the nucleus, whereas aABC staining was completely absent. These results
indicate that the b-catenin accumulating in the nucleus of this tumor is
phosphorylated. Recently we have shown that this pool of b-catenin is unlikely
to be signaling and to play a role in the pathogenesis of this particular tumor.
Table 1. Overview of the parameters scored for 20 mammary gland tumors
1 according to Bloom and Richardson
The fourth possible combination was a grade III ductal tumor, which showed
expression of E-cadherin, but where no nuclear signal was observed with the
aABC antibody (Fig. 4D). One last example to emphasize that no correlation
can be found between the parameters was a lobular mammary tumor, grade II,
which was positive for E-cadherin, yet displayed signaling-competent b-catenin
in the nucleus (Fig. 5). Thus, the absence of E-cadherin did not automatically
result in increased levels of dephosphorylated b-catenin in the nucleus. This
could be explained by the fact that aABC did not always stain the adherens
junctions, implying that the majority of the b-catenin molecules in the adherens
junctions might be phosphorylated. If the adherens junctions would be
disrupted, this would then not influence the levels of signaling-competent b-
catenin. Lack of E-cadherin expression did not correlate with increased
numbers of affected lymph nodes in this study, probably due to the relative
small number of tumors investigated, though loss of E-cadherin has been
Tumor type Diff. Grade1 MAI Lymph nodes E-cadherin aABC
ductal I 2 0/27 pos neg
ductal I 2 0/10 pos pos
ductal I 5 1/4 pos neg
ductal II 1 ? pos neg
ductal II 2 1/3 pos pos
ductal II 2 1/23 pos pos
ductal II 4 1/23 neg pos
ductal III 9 1/16 pos pos
ductal III 10 0/26 neg neg
ductal III 17 0/14 pos neg
ductal III 46 6/14 neg pos
ductal III >10 1/7 pos pos
ductal V 3 0/19 pos pos
lobular II 0 0/1 neg pos
lobular II 1 ? pos pos
lobular II 2 0/26 neg pos
lobular II 2 0/11 neg pos
lobular II 3 0/24 neg pos
lobular II 4 0/8 neg pos
lobular II 4 18/27 pos neg
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reported to correlate with invasiveness and metastasis. Evidently, no
correlation was found between the presence of aABC signal and the
differentiation grade of the tumor.
Figure 4. Samples of ductal breast carcinomas. A) This tumor is positive for E-cadherin as well as
signaling-competent b-catenin. B) A tumor sample is shown which lacks E-cadherin, but is positive for
the presence of signaling-competent b-catenin. C) Another tumor was negative for E-cadherin as well
as for signaling-competent b-catenin, whereas the TL antibody remained positive. The tumor depicted
in D) has not lost its E-cadherin at the membrane but does not show any aABC signal. The TL
antibody does show b-catenin in this sample.
Breast carcinoma cell lines do not show elevated levels of signaling â-
catenin
Van de Wetering et al. showed that in a panel of breast carcinoma cell lines the
activity of the Wnt signaling cascade was only increased in 1 of 20 cell lines.
The only cell line with an activated Wnt pathway harbored a rare mutation in
APC. To extend the study of the cell line panel, we analyzed the presence of
signaling-competent b-catenin in nine of the breast cell lines and in a colon
carcinoma cell line (Fig. 6, upper panel). b-catenin was detectable in all cell
lines with the exception of the cell lines SKBR-3 and -5. This correlated strictly
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with the presence of E-cadherin (van de Wetering et al., 2001). Only the APC-
mutant breast cell line DU4475 showed a substantial amount of the signaling
pool of b-catenin as visualized by the aABC antibody (Fig.6 lower panel). These
data confirmed that in breast carcinoma cell lines, an increase of signaling
competent b-catenin resulting from Wnt pathway mutations is a rare event.
Furthermore, these data confirmed that loss of E-cadherin results in the loss of
a large pool of b-catenin, presumably by cytoplasmic degradation. Apparently,
the absence of E-cadherin does not liberate any signaling-competent b-catenin.
Figure 5. This lobular breast carcinoma shows E-cadherin at the membrane, but is also positive for
signaling-competent b-catenin in the nuclei of the tumor cells.
The involvement of Wnt signaling in tumor formation in breast carcinomas is
underscored by our observation that 70% of the tumors investigated were
positive for signaling-competent b-catenin in the nucleus. Yet, the analysis of
the breast cancer cell line panel argues against the presence of mutations in
the Wnt cascade that would lead to the accumulation of signaling-competent â-
catenin. Assuming that the cell lines are representative, these two observations
provide a paradox. We propose that transformed epithelial cells in the breast
may receive Wnt signals from the surrounding tissue. This would lead to the
observed accumulation of nuclear, signaling-competent b-catenin. Yet, cell lines
derived from such tumors would no longer receive Wnt signals when cultured.
Obviously, the panel of breast tumors should be extended and also panels of
cancers originating from other tissues should be investigated. Nevertheless the
presence of nuclear b-catenin, which is actively signaling, could become a
significant diagnostic marker in the future.
Figure 6. Nine breast
tumor cell lines and a
colon carcinoma as the
positive control were
analyzed for the
presence of total â-
catenin (upper panel)
and of the signaling-
competent pool (lower
panel). The cell lines
depicted are: 1.
DU4475; 2. MDA-MB-
361; 3. OCUB-F; 4.
BT20; 5. MDA-MB-468;
6. MDA-MB-435S; 7.
SKBR-5; 8. SKBR-3; 9.
MPE600; 10. LS174.
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Abstract
The so called destruction complex acts at the heart of the canonical Wnt
signaling cascade by phosphorylating b-catenin, thus marking it for rapid
proteasomal degradation. The destruction complex contains APC, axin and the
constitutively active serine kinase GSK3. Wnt signaling inhibits GSK3. As a
consequence, b-catenin is stabilized and can form nuclear complexes with TCF
factors to activate transcription of TCF target genes. Four conserved Ser/Thr
residues in the N-terminus of b-catenin constitute the targets of GSK3. Several
aspects of the regulated phosphorylation of b-catenin have remained
unresolved to date. Here we provide evidence that the pool of non-
phosphorylated b-catenin that transduces the Wnt signal is synthesized de
novo, and is not generated by dephosphorylation of a preexisting pool. We also
show that the phosphorylation of the four regulatory Ser/Thr residues does not
proceed in an N-terminal direction, as is generally presumed for GSK3:
Mutation of either the N- or the C-terminal Ser residue inhibits the
phosphorylation of the two middle Ser/Thr residues.
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Introduction
b-catenin, the vertebrate homologue of Drosophila armadillo, plays a
central role in tissue homeostasis and embryonic patterning (Barth et al.,
1997). It was originally discovered as a protein involved in cell-cell adhesion
(Nagafuchi and Takeichi, 1989; Ozawa et al., 1989). b-catenin links E-cadherin
to a-catenin, which thereby connects the actin microfilament network of the
cytoskeleton to the adherens junctions (Cox et al., 1996; Orsulic and Peifer,
1996). Based on genetic analyses of its fly orthologue Armadillo, it was
subsequently found that b-catenin is a key mediator in the Wnt/Wingless
signaling cascade.
Wnt proteins are secreted, cystein-rich glycoproteins. In the absence of
Wnt signals, newly synthesized b-catenin is rapidly degraded. b-catenin
associates with a large cytoplasmic protein ensemble, the destruction complex.
This complex contains the gene product of the adenomatous polyposis coli
(APC) gene, the scaffolding protein Axin/conductin and the serine/threonine
kinase glycogen synthase kinase-3b (GSK-3b). In this complex, b-catenin is
phosphorylated at its N-terminus at four consensus GSK-3b phosphorylation
sites (Behrens et al., 1998; Cox and Peifer, 1998; Ikeda et al., 1998).
Phosphorylated b-catenin is specifically recognized by the F-box protein b-TrCP.
The latter protein determines the substrate specificity of an E3 ligase
ubiquitination complex by selectively recruiting phosphorylated substrates via
its WD40 repeats (Skowyra et al., 1997). Indeed, phosphorylated b-catenin is
ubiquitinated (Ciechanover, 1994), and is thereby targeted for degradation by
the proteasome (Hart et al., 1999).
Wnt factors bind to a surface receptor complex consisting of a Frizzled
serpentine receptor associated with LRP5/6, a type I transmembrane receptor
related to the LDL receptor (Bhanot et al., 1996) The interaction results in the
inhibition of GSK-3b within the destruction complex. As a consequence, b-
catenin is no longer phosphorylated and accumulates. It then translocates to
the nucleus where it forms a bipartite transcription factor with members of the
TCF/LEF family of DNA-binding proteins (Behrens et al., 1996; Molenaar et al.,
1996; Brunner et al., 1997; Riese et al., 1997; van de Wetering et al., 1997).
Four N-terminal residues of b-catenin are believed to be phosphorylated by
GSK-3b: S33, S37, T41 and S45 (Behrens et al., 1998; Kishida et al., 1998;
Ikeda et al., 1998). Indeed, mutations within or directly flanking these residues
are regularly found in tumors of various origins. A comprehensive table of
these mutations can be found at www.ana.ed.ac.uk/rnusse/pathways/bcatmut.
html.
The exact mechanisms that control the phosphorylation status of b-
catenin are largely unresolved. First, formal proof for the phosphorylation of
the four pertinent Ser/Thr residues does not exist. Second, while the cytoplasm
contains multiple constitutively active phosphatases, some of which interact
with components of the destruction complex (Hsu et al., 1999; Seeling et al.,
1999; Ikeda et al., 2000), it is unclear whether the non-phosphorylated pool of
b-catenin that mediates Wnt signals derives from the preexisting pool of
phosphorylated b-catenin or has to be synthesized de novo.
Third, the notion that phosphorylation of all four Ser/Thr residues
renders b-catenin inactive has been challenged by the observation that the
simultaneous replacement of all four Ser/Thr residues by the phosphorylation
______________________________________________________________Chapter 5
68
mimic Asp yields a mutant b-catenin that is highly stabile (Dajani et al., 2001;
Thomas et al., 1999).
Fourth, it is unclear how GSK-3b phosphorylates the N-terminus of b-
catenin. GSK-3b is known to phosphorylate SxxxS motifs in substrates such as
glycogen synthase only when the Ser at position +4 is phosphorylated by a
priming kinase (Thomas et al., 1999). Priming of glycogen synthase for
instance is performed by casein kinase II (Fiol et al., 1988; Cohen, 1999). This
model suggests that the S33xxxS37xxxT41xxxS45 motif could be
phosphorylated in a sequential fashion by GSK3 once S45 has been
phosphorylated. Here we address some of these unresolved issues. We show
that the presence of a constitutively active phosphatase is unlikely. While
changing all four phosphorylation sites into Asp generates a dominant positive
form of b-catenin, we show that substituting single Ser/Thr residues by Asp at
two of the positions mimics the normal phosphorylation of wt b-catenin. Finally
we could answer the question if b-catenin phosphorylation is primed and that
priming is likely to occur from the +4 position upwards.
Materials and Methods
Cell lines and reagents
All cell line were cultured in RPMI, complemented with 10 % fetal calf serum, penicillin and
streptomycin. Cyclohexamide was obtained from Sigma, LiCl from Riedel de Haen.
Metabolic labeling
SKBR-3 cells were grown in 60 mm dishes until grown at 70% confluency. The cells were incubated in
methionine- and cysteine-free MEM (Gibco). The cells were pulsed with [35S]methionine/cysteine (200
ìCu/ml, Ready Vue, Amersham) for 10 minutes in a 37ºC CO2 incubator. The radioactivity was
replaced with RPMI/10% FCS medium containing 100 ìM unlabeled methionine and cysteine and
chased for 0-45 minutes. Cells were lysed and samples immunprecipitated (see below). Radioactivity
was determined with the use of a Storm imaging system (Molecular Dynamics) and quantified with
Molecular Dynamics Image QuaNT software.
Cell Lysis and Immunoprecipitations
Cells were lysed on ice in 1 ml of lysis buffer containing 20 mM Tris pH 8.0, 1% Triton-X-100, 140 mM
NaCl and 10% glycerol and protease inhibitors (Complete, Roche). Ten ìl AG beads were incubated
with the 2 ìg TL antibody per immunoprecipitation for 1 hour at 4ºC. The lysates were incubated with
these beads over night at 4ºC. The immunoprecipitates were washed three times in a buffer
containing 20 mM Tris pH 8.0, 150 mM NaCl and 0.5% NP40. The complexes were dissolved on a 10%
SDS Page gel.
Mammalian expression constructs
The b-catenin mammalian expression constructs were generated in pCIneo [Promega]. The
construction of pCIneo-S33Y b-catenin and pCIneo-D45b-catenin, encoding a b-catenin molecule with
a S to Y mutation at amino acid 33 or a deletion at codon 45, was described previously (Morin et al.,
1997). The mutants S33D, S37D, S37A, T41D, T41A and S45D were generated by PCR and subcloned
into pGEM [Promega]. The primers used were:
pCIneo SacI 5’: GTC TAT ATA AGC AGA GCT C, S33D 5’: GAC GAC GGA ATT CAT TCT GGT GCC ACT;
S33D 3’: ATG AAT TCC GTC GTC CAG GTA AGA CTG, S37D 5’: CAT GAC GGT GCC ACT ACC ACA G;
S37D 3’: GGT AGT GGC ACC GTC ATG GAT TCC AGA; S37A 5’: GAA TCC ATG CCG GCG CCA CTA CCA
CAG CTC; S37A 3’: GGT AGT GGC GGC GGC ATG GAT TCC AGA GTC; T41A 5’: TCT GGC GCC ACT
GCC ACA GCT CCT TCT C; T41A 3’: GAG CTG TGG CAG TGG CGC CAG AAT GGA TCC A, T41D 5’: CAC
TGA CAC AGC TCC TTC TCT G; T41D 3’: GAG AAG GAG CTG TGT CAG TGG CAC CAG AAT G; S45D 5’:
CCT GAT CTG TCC GGA AAA GGC AAT CCT GAG; S45D 3’: GCC TTT TCC GGA CAG ATC AGG AGC TGT
GGT AGT; b-cat SapI 3’: GGT CAG ATG ACG AAG AGC. After sequencing, the pCIneo-WT b-catenin N-
terminus was replaced by the mutant N-termini using NheI and XhoI.
Luciferase reporter assays
2.5 x 10 5 293T cells were transfected using FuGENE 6 reagent [Roche] according to the
manufacturer’s recommendations. The cells were transfected with the following:
100 ng of luciferase reporter plasmid (either pTOP-Glow, containing three optimal Tcf binding sites
upstream of a TATA-box (Vermeulen et al., 1996), or its negative control, pFOP-Glow, containing
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mutated Tcf binding sites); 20 ng of pCMV-RNL encoding Renilla luciferase as an internal control for
transfection efficiency [Promega]; 300 ng of the b-catenin constructs and, where appropriate, pCi to
equilibrate the amount of plasmid DNA transfected. Cells were incubated for 24 h post-transfection
prior to further analysis.
Luciferase activities were determined using the DUAL Luciferase Reporter (DLR) system [Promega]
according to the manufacturer's protocol. Reporter luciferase activity was normalized relative to
Renilla-luciferase activity. Transfections were performed in duplicate and three independent
experiments were performed
Western Blots
For detection of dephosphorylated b-catenin protein, cells were directly lysed in 200 m l of
hot 2X SDS-PAGE sample buffer (15 mM 1 M Tris pH6.8, 5% SDS, 40% Glycerol, 0.005% BPB, 8% b-
MeOH), vortexed vigorously, denatured by heating at 98oC for 5 min, and cleared by centrifugation for
5 min at 21,000 g. The samples treated with calf intestine phosphatase were rinsed with PBS,
sonicated in PBS with protease inhibitors, prior to adding of the 10 units of calf intestine phosphatase
for 5 min at 32°C. 20 m l of protein extract was resolved on a 10% (w/v) denaturing polyacrylamide
gel, and transferred to PVDF membrane [Immobilon-P, Millipore]. b-catenin protein was detected by
probing the blot with aS29NP, aABC, a commercially available pan a-b-catenin antibody [Transduction
Laboratories, clone 14] and a commercially available antibody specific for non-phosphorylated S33
[Alexis] called 8E4. This was followed by a horse-radish- peroxidase-conjugated rabbit anti-mouse IgG
polyclonal antibody [Pierce], and finally visualized by enhanced chemiluminescence [Amersham].
These experiments were conducted three times, a representative blot was chosen for figures 1 and 4.
Results and Discussion
b-catenin accumulation requires de novo synthesis
The binding of Wnt factors to their receptors leads to downregulation of the
kinase activity of GSK-3b. The consequence is that b-catenin is not
phosphorylated and cannot be recruited to the ubiquitination system as b-TrCP
only recognizes the phosphorylated form of its substrates (Feldman et al.,
1997; Skowyra et al., 1997). We asked whether Wnt signaling requires de
novo synthesis of unphosphorylated b-catenin, or if the latter may be
generated from a pre-existing pool by dephosphorylation. To this end, we
applied  LiCl as a pharmacological inhibitor of GSK3 activity. LiCl readily
induces the accumulation of unphosphorylated b-catenin and activates TCF-
reporter genes (Stambolic et al., 1996). We reasoned that the addition of the
protein synthesis inhibitor cyclohexamide should inhibit the accumulation of
unphosphorylated b-catenin, if the latter is generated de novo, but not if it
derives from a pre-existing pool of phosphorylated b-catenin. A practical
complication of the study of posttranslational modifications of b-catenin is
presented by the fact that epithelial cells contain a large pool of highly stable b-
catenin which is associated with E-cadherin in adhesion junctions. To accurately
monitor modifications in the much smaller signaling pool of b-catenin, we
performed our experiments in SKBR-3 breast carcinoma cells, which carry a
homozygous deletion of the E-cadherin gene. Consequently, all b-catenin in
these cells resides in the signaling pool (van de Wetering et al., 2001). SKBR-3
cells were simultaneously treated with cyclohexamide and LiCl in various
combinations. Cells were lysed at various time points and analyzed on Western
Blots (Fig. 1). The blots were first probed with a pan-b-catenin antibody (TL,
Fig. 1A). As expected, the total amount of b-catenin increased upon LiCl
stimulation (lanes 2 and 6). This effect was abolished by the addition of
cyclohexamide.
We probed these samples also with an antibody, which specifically recognizes
S33 in its unphosphorylated state (8E4, Fig. 1B). The epitope of this antibody
was readily expressed upon LiCl treatment (lanes 2 and 6), but was completely
absent when the cells were treated with cyclohexamide. We interpreted these
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observations as evidence for the notion that non-phosphorylated b-catenin is
synthesized de novo and cannot be generated from pre-existing
phosphorylated b-catenin.
Figure 1. b-catenin accumulation requires de novo synthesis. A) SKBR-3 cells are treated with
either cyclohexamide or LiCl or both for 1 or 3 hours. Cell lysates were separated on a 10% SDS page
gel. The blots were stained for b-catenin with the TL monoclonal antibody. B) The same lysates were
also analyzed for the amount of b-catenin which is not phosphorylated on S33.
The observed kinetics implied that b-catenin turnover must be extremely high,
much higher than the estimated half-life of b-catenin of 4 hours (Guger and
Gumbiner, 2000). Of note, this half-life was determined in cells containing
cadherins, which complicate biochemical analysis of b-catenin for the reason
mentioned above. Therefore, we determined the turnover rate of b-catenin in
the SKBR-3 cells, which do not contain a cadherin-bound pool of b-catenin
(Fig.2A). Two approaches were taken. 1) The cells were stimulated with LiCl for
different durations. We took as an assumption that the LiCl treatment would
not affect production rates of b-catenin, but that its degradation would be fully
inhibited. This would then allow the calculation of the half-life of steady state b-
catenin protein. After 15 minutes of LiCl treatment, overall b-catenin levels had
risen 1.6 fold. The quantified b-catenin levels are visualized graphically (Fig.
2B). This allowed the estimation of a turnover rate of 17 minutes. (It took 17
minutes to double the amount of b-catenin from 8 to 16 arbitrary units.)
Figure 2. The turnover rate of b-catenin is
approximately 17 minutes. A) SKBR-3 cells
were treated for different time points with LiCl
and analyzed on Western blots. The blots were
stained for b-catenin and actin to control for
equal loading. B) The b-catenin bands were
quantified. From the graph the estimated half
life could be deduced.
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2) The second method to determine the half life of the signaling pool of b-
catenin was a pulse-chase experiment. SKBR-3 cells were labeled with 35S-
Methionine for 10 minutes. The radioactive label was then chased for 0-45
minutes. Cells were lysed at the indicated time points, b-catenin was
immunoprecipitated and separated on a SDS page gel (Fig 3 upper panel). The
bands representing b-catenin were quantified, which allowed us to determine a
half life of approximately 17 minutes (Fig. 3 lower panel).  Thus, the half-lifes
of b-catenin in the non-membrane-bound signaling pool as determined by the
two independent methods agreed well, being in the order of 17 minutes. The
measured half-life was substantially shorter then the previously reported 4
hours, which may arguably reflect inherent differences between the cell lines
used (Guger and Gumbiner, 2000). Nevertheless, a turnover rate of 17 min
was compatible with the notion that the unphosphorylated b-catenin that
accumulates during Wnt signaling with the kinetics given in Figure 1 can indeed
be synthesized de novo. In addition these kinetics explain how signaling
through the Wnt cascade can be a relatively rapid process.
Figure 3. The half life of b-catenin is 17 minutes. A) SKBR-3 cells were pulsed for 10 minutes
with 35S methionine and chased for 0-45 minutes. b-catenin immunoprecipitates were separated on an
SDS Page gel. The quantified bands are depicted in graph B.
Aspartic acid substitutions of the 4 GSK-3b phosphorylation sites result
in opposed outcomes.
The substitution of Ser by Asp residues is often used to mimic phosphorylation.
It would thus be predicted that the introduction of four Asp residues at the
pertinent Ser and Thr position would create a b-catenin molecule with the high
turnover of a phosphorylated wt b-catenin molecule. However, Guger et al
reported that substituting all four putative GSK-3b target residues by Asp
(4*D) unexpectedly resulted in a highly stable b-catenin molecule capable of
potently activating TCF as measured in the Xenopus double axis assay. These
______________________________________________________________Chapter 5
72
mutations were as potent as substituting the phosphorylation sites by alanines
(4*A) (Guger and Gumbiner, 2000). These observations argued against
phosphorylation as the principal signal for b-catenin degradation, unless the
four substitutions create a structure which deviates significantly from that
created by phosphorylation of the four regulatory Ser and Thr residues.
We assessed the transcriptional activity of both mutants compared to wild-type
(WT) b-catenin in a b-catenin-Tcf reporter gene assay (van de Wetering et al.,
2001)  (Figure 4). As predicted from the Xenopus experiments, the 4*D
substitutions displayed the same strong transcriptional activity as the 4*A
mutant, relative to the wt b-catenin.
Figure 4. Asp substitutions of
the GSK phosphorylation sites
do not mimic phosphorylation.
293T cells were co- ransfected with
xenopus WT b-catenin (WT), a
construct encoding xenopus â-
catenin, with the serines
substituted by alanines (4*A), the
counterpart where the serines are
substituted with four asp residues
(4*D), and either the TOP-glow or
FOP-glow reporter constructs. After
24 hours a reporter gene assay
was performed. Fop values were so
low that they are not visible in this
representation.
We then asked if substitution of single Ser/Thr residues would cause a similar
activation. Constructs were made with either an Asp or one of the substitutions
found in tumors at each individual position. These mutant b-catenin constructs
were again co-transfected with the Tcf reporter genes (Fig. 5). Surprisingly, not
all mutants were similarly capable of activating reporter gene expression. As
expected, all mutations found in tumors yielded very potent transcriptional co-
activators, as did the S33D and S45D replacements. In contrast, S37D and
T41D behaved like WT b-catenin (Fig. 5). Apparently, the Asp substitutions at
positions 37 and 41 did mimic phosphorylation of Ser37 and Thr41
respectively.
Figure 5. S37D and T41D
substitutions do not alter the
transcriptional activity of b-catenin
in contrast to S33D and S45D.
293T cells were co-transfected with â-
catenin constructs of which the
serines/threonine were either mutated
as found in tumors (S33Y, S37A,
T41A, D45) or substituted with asp
residues (S33D, S37D, T41D, S45D),
and either the TOP-glow or FOP-glow
reporter constructs. After 24 hours a
reporter gene assay was performed.
Fop values were so low that they are
not visible in this representation.
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Phosphorylation of b-catenin by GSK-3b is primed
Recently, the crystal structure of GSK-3b was solved (Dajani et al., 2001; ter
Haar et al., 2001). The results obtained by Dajani et al. contradicted earlier
findings that b-catenin phosphorylation was unprimed (Thomas et al., 1999),
as the authors state that b-catenin phosphorylation is primed. The conclusion
that b-catenin phosphorylation is unprimed are based on data showing that b-
catenin phosphorylation is sensitive to inhibition by FRATtide, a peptide
corresponding to residues 188-226 of FRAT1, a homologue of GSK-3b binding
protein (GBP). In contrast, FRATtide does not suppress GSK-3b activity towards
other substrates, such as glycogen synthase and eIF2B, whose phosphorylation
is dependent on a 'priming' phosphorylation (Thomas et al., 1999). Not only
S33, S37, T41, and S45 are putative phosphorylation sites of GSK-3b. We have
recently found that phosphorylation of S23 and S29 is also mediated by GSK-
3b (van Noort, et al. submitted). The phosphorylation status of S29 is very
tightly regulated during development and is sensitive to LiCl treatment.
Phosphorylation of this serine might influence phosphorylation of the other
serins/threonine or vice versa. With the panel of mutants and antibodies
specific for the non-phosphorylated status of either S29 (aS29NP) or S37/T41
(aABC), we tried to address the question of primed versus non-primed
phosphorylation. If phosphorylation would be primed, these antibodies should
also reveal the relative order of phosphorylation. Therefore 293T cells were
transfected with the different b-catenin constructs, the cells were lysed and
analyzed on Western Blot (Fig.6). To control for equal loading, the blot was
probed with a pan b-catenin antibody (Fig. 6, upper panel). Strong signals were
detected with the aABC monoclonal in the lane with S41A and D45 (Fig. 4 lower
panel, lanes 5 and 6). The antibody specific for non-phosphorylated S29 also
showed increased signals with all mutants (Fig. 6, second panel, lanes 3-6),
indicating that b-catenin phosphorylation by GSK-3b is primed. If
phosphorylation would be unprimed, the unavailability of one phosphorylation
site would not influence the phosphorylation status of the other sites and the
monoclonals should not exhibit increased immunoreactivity towards S33Y and
D45 b-catenin. Mutations in S33, however did not alter the phosphorylation
status of S37 and T41. In contrast, the phosphorylation status of S29 is
influenced by mutations in S37, T41 and S45 (Fig. 6, second, lanes 4, 5 and 6).
These data lead to the conclusion that phosphorylation of b-catenin starts at
S45. Our hypothesis would be that after S45, T41 would be phosphorylated,
followed by S37. With the available antibodies we could show that S29 is the
last serine to be phosphorylated. As the phosphorylation of glycogen synthase
by GSK-3b is primed by casein kinase 2, it is likely that b-catenin
phosphorylation is also primed by a kinase (Cohen, 1999; Fiol et al., 1988).
The identification of this kinase will contribute to the understanding of the
regulation of b-catenin activity.
In conclusion, we have tried to address several unresolved issues regarding
GSK-3b phosphorylation of the N-terminus of b-catenin. First, we show that b-
catenin accumulation upon LiCl stimulation requires de novo synthesis of b-
catenin and that the activity of a constitutively active phosphatase can be ruled
out. Secondly, the substitution of all phosphorylation sites by aspartic acid
residues results in a dominant active form whereas single amino acid
substitutions have different outcomes. The S33D and S45D are dominant
positive forms of b-catenin, whilst S37D and T41D behave like WT b-catenin.
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Thirdly, the issue of primed versus non-primed phosphorylation is solved in
favor of the first, though no specific order of phosphorylation could be deduced.
It would be very interesting to investigate the nature of the priming kinase.
Figure 6. The phosphorylation of b-catenin is primed and occurs from S45 upwards. 293T
cells were transfected with the WT b-catenin and b-catenin constructs harboring the mutations found
in tumors. After 24 hours the cells were lysed and analyzed on Western Blots. The upper panel
represents the presence of the total pool of b-catenin, whereas the middle panel shows specifically the
pool of b-catenin, which is non-phosphorylated on S29. The lower panel indicates the amount of b-
catenin which is non-phosphorylated at S37.
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Abstract
b-catenin plays a key role in the Wnt signaling cascade. The levels of b-catenin
within a cell are regulated via phosphorylation of the N-terminus of b-catenin
by GSK-3b. The phosphorylation leads to ubiquitination and subsequent
degradation of the protein. Thus far three serines (S33,37,45) and one
threonine (T41) are considered to be the substrates for GSK-3b
phosphorylation. Indeed, these amino acids are regularly mutated in tumors,
resulting in â-catenin molecules with enhanced transcriptional activity. Aligning
N-terminal sequences of b-catenin homologues of different species revealed
two other highly conserved serines (S23,29), which have also been found
mutated in tumors. We show that these serines are modified in the same
fashion as the known regulatory residues. During embryogenesis, the
phosphorylation status of S23 and S29 appears to be actively regulated.
Nevertheless, constructs harboring the mutations found in tumors fail to show
enhanced transcriptional activity or transforming properties.
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Introduction
b-catenin, the vertebrate homologue of Drosophila armadillo, plays
critical roles in embryonic patterning, cell fate determination and tissue
homeostasis [1]. The protein was first identified by virtue of its interaction with
E-cadherin, the principal adhesion molecule in epithelial adherens junctions. b-
catenin links E-cadherin to a-catenin, which in turn couples the complex to the
actin microfilament network of the cytoskeleton [2,3].
 Genetic and embryological studies have revealed that b-catenin
performs a second function, i.e. it is able to transduce signals upon induction
by Wnt molecules. Wnt proteins constitute a large family of cystein-rich
secreted ligands that control development and cell proliferation. In resting
cells, cytosolic b-catenin resides in a large complex, consisting of the
serine/threonine kinase GSK-3b, Axin or Conductin proteins and the product of
the adenomatous poliposis coli (APC) gene. This complex promotes the
phosphorylation of the N-terminus of b-catenin by GSK-3b at its consensus
GSK-3â phosphorylation sites [4-6]. Phosphorylated b-catenin is then targeted
for ubiquitination by interacting with the adaptor protein b-TrCP. This F-box
protein determines the substrate specificity for ubiquitination by selectively
recruiting phosphorylated substrates via its WD40 repeats [7,8]. b-catenin is
tagged with multiple copies of the small protein ubiquitin [9], resulting in rapid
degradation by the proteasome, a large multisubunit proteolytic complex [10].
Following binding of Wnt to its receptor, the kinase activity of GSK-3b
is inhibited and the b-catenin-APC-Axin complex dissociates. b-catenin is then
no longer phosphorylated and thus no longer degraded, and will accumulate. b-
catenin translocates to the nucleus where it forms a bipartite transactivation
complex with members of the TCF/LEF family of transcription factors,
ultimately resulting in target gene expression (reviewed by Barker et al.,
2000).
The N-terminus of b-catenin harbors four putative GSK-3b
phosphorylation sites. These highly conserved residues are three serines, S33,
S37, S45 and a threonine, T41, all encoded by exon 3 of the human b-catenin
gene (CTNNB1) [11]. Serines 33 and 37 are not only putative phosphorylation
sites, these serines also constitute a part of a 6 amino acid stretch important
for ubiquitination, similar to I-kB [12,13]. Deletion of this part of the N-
terminus or mutation of any one of these four residues generates a form of b-
catenin which can no longer be phosphorylated and degraded [14,15]. These
gain-of-function mutations lead to constitutively active transactivation
complexes, which appear to contribute to loss of cell growth control. Many
tumors have been screened for mutations in exon 3 of the CTNNB1 gene and,
indeed, mutations are found in these four residues (for overview see
www.ana.ed.ac.uk/rnusse/pathways/ bcatmut. html). These analyses indicate
that a mutation in only one of the serines or threonine is sufficient to create a
dominant positive form of b-catenin.
Aligning the N-terminal b-catenin sequences of several species showed
two additional highly conserved serines, S23 and S29. Mutations in these
serines have been discovered in gastric and hepatocellular tumors [16,17].
These findings prompted us to investigate whether these serines are also
involved in the regulation of b-catenin activity. We report here that S23 and
S29 appear to be subject to phosphorylation as found for the other known
regulatory sites. During embryogenisis the phosphorylation status differs
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between S23 and S29, which suggests they perform differentially regulated
functions. However, mutations in S23 or S29 do not influence the
transcriptional activity or transforming abilities of b-catenin.
Experimental Procedures
Cell lines and reagents
SKBR-3, 293T, Jurkat and RK3E cell lines were cultured in RPMI, complemented with 10 % fetal calf
serum, penicillin and streptomycin. ALLN (N-acetyl-Leu-Leu-norleucinal) was obtained from Sigma.
Mammalian expression constructs
b-catenin N-terminal deletion constructs were generated in pCDNA3neo [Invitrogen] by polymerase
chain reaction (PCR) and subcloned in the pGEM-T vector [Promega]. The following primers were
used:
WTmyc 5’: CCA AGG ATC CAC CAT GGA GCA GAA GCT GAT CAG CGA GGA GGA CCT GAT GGC TAC
TCA AGC TGA TTT G, D19 5’: CAA GGA TCC ACC ATG GAG CAG AAG CTG ATC AGC GAG GAG GAC CT
CGG CTG TTA GTC ACT GG; D26 5’: CCA AGG ATC CAC CAT GGA GCA GAA GCT GAT CAG CGA GGA
GGA CCT GCA ACA GTC TTA CCA CCT GGA CTC T; D31 5’: CCA AGG ATC CAC CAT GGA GCA GAA GCT
GAT CAG CGA GGA GGA CCT GGA CTC TGG AAT CCA TTC TGG T; D 3’: CGG TTG CCT CGA GTC ATT
GCA TAC TGT CCA TC. After confirmation of the sequence the N-terminal fragments were cloned into
pCDNA3neo with the c-terminal part of b-catenin via a BamHI/XhoI digestion. The b-catenin
mammalian expression constructs were generated in pCIneo [Promega]. The construction of
pCIneoS33Y-b-catenin and pCIneo-D45b-catenin, encoding a b-catenin molecule with a S to Y
mutation at amino acid 33 or a deletion at codon 45, was described previously [14]. The mutants
S34R, S29F, S37A and T41A were generated by PCR and subcloned into pGEM [Promega]. The
primers used were:
pCIneo SacI 5’: GTC TAT ATA AGC AGA GCT C, S23R 5’: GCG GCC GTA CGA CAC TGG CAG CAA CAG;
S23R 3’: CTG CCA GTG TCG TAC GGC CGC TTT TCT GTC T, S29F 5’: CAA CAG TTC TAT CTA GAC TCT
GGA ATC CAT; S29F 3’: CCA GAG TCT AGA TAG AAC TGT TGC TGC CAG T; S37A 5’: GAA TCC ATG
CCG GCG CCA CTA CCA CAG CTC; S37A 3’: GGT AGT GGC GGC GGC ATG GAT TCC AGA GTC; T41A
5’: TCT GGC GCC ACT GCC ACA GCT CCT TCT C; T41A 3’: GAG CTG TGG CAG TGG CGC CAG AAT GGA
TCC A, â-cat SapI 3’: GGT CAG ATG ACG AAG AGC. After sequencing, the pCIneo-WT b-catenin N-
terminus was replaced by the mutant N-termini using NheI and XhoI.
Mouse anti-b-catenin S23/S29 monoclonal antibody production
A 300 bp PCR product encoding the first 100 amino acids of human b-catenin protein was cloned into
pET21a [Novagen] and used to generate His-tagged recombinant protein from BL21 E. coli. Six week
old BALB/c mice were immunized with 200 mg of purified b-catenin(1-100) fusion protein in Freund’s
complete adjuvant [Difco], with a second injection in Freund’s incomplete adjuvant [Difco] 14 days
later. The splenocytes of the immunized mouse were fused to SP2/0 mouse myeloma cells using a
standard polyethylene glycol protocol as described previously [18]. The fused cell population was
resuspended in hypoxanthine aminotropterin thymidine selection medium [Life] and plated into 96-
well flat bottom culture plates. Positive clones were subcloned to obtain clonal hybridomas.
Monoclonal antibodies from subclones 9F12 and 22H8 were used in the experiments described,
referred to as aS29NP and aS23NP respectively.
Cos cell staining
10 6 Cos cells were transfected with 1 mg of the deletion constructs using DEAE Dextran and fixed in
methanol 2 days later. After rinsing the plates, the cells were incubated with hybridomas supernatants
for 60 min, by followed washes and incubation with peroxidase labelled Rabbit-a-Mouse 1:100 [DAKO]
for 30 min and AEC/H 2O2.
Pepscan
Pepscan analysis were performed by Pepscan Bv., Lelystad, The Netherlands
Peptide ELISA
Covalink ELISA plates [Nunc] were activated by incubation with 100 m l 10 mM SPDP (3-(2-
pyridyldithio)propionic acid N-hydroxysuccinimide ester) [Sigma] in PBS for 30 min at 37 °C. The
plates were rinsed with aqua dest. several times. The peptides used to coat were CDRKAAV S(-P)
HWQQQ and CWQQQ S(-P) YLDSG. 10 mM peptides in 0.1 M Tris-HCl, pH 8.0 were directly coupled to
the bivalent linker via the N-terminal cystein residue for 60 min at 37°C, followed by several washes
with aqua dest. The coated plates were blocked with PBS/0.25% BSA during 15 min. Subsequently
the plates were washed with water. The monoclonal antibodies were allowed to bind for 45 min at
37 °C, rinsed with water, followed by peroxidase labeled Rabbit a-Mouse [DAKO] for 30 min at 37 °C .
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After washing, the staining was visualized by adding ABTS (2’,2’-Azino-Bis(3-Ethylbenzthiazoline-6-
Sulphonic Acid) Diammonium, Boehringer)/H 2O2 and measuring the absorbance at 405 nm. The
experiment was repeated 3 times with duplo measurements, yielding essentially identical results.
Western Blots
For detection of endogenous b-catenin protein, 106 sample cells were directly lysed in 200 ml of hot 2X
SDS-PAGE sample buffer (15 mM 1 M Tris pH6.8, 5% SDS, 40% Glycerol, 0.005% BPB, 8% b-MeOH),
vortexed vigourously, denatured by heating at 98oC for 5 min, and cleared by centrifugation for 5 min
at 21,000 g. The samples treated with calf intestine phosphatase were rinsed with PBS, sonicated in
PBS with protease inhibitors, prior to adding of the 10 units of calf intestine phosphatase for 5 min at
32 °C. 20 m l of protein extract was resolved on a 10% (w/v) denaturing polyacrylamide gel, and
transferred to PVDF membrane [Immobilon-P, Millipore]. b-catenin protein was detected by probing
the blot with aS23NP, aS29NP or a commercially available a-b-catenin antibody [Transduction
Laboratories, clone 14] followed by a horse-radish- peroxidase-conjugated rabbit anti-mouse IgG
polyclonal antibody [Pierce], and finally visualized by enhanced chemiluminescence [Amersham].
These experiments were conducted three times, a typical blot was chosen for figure 3.
Immunohistochemistry
Tissue samples were fixed in formalin, embedded in paraffin, and sectioned at 5 mm thickness.
Endogenous peroxidase activity was blocked by incubating the cells in 1.5% peroxide in methanol for
20 minutes. The slides were subsequently immersed in 0.01 mol/L citrate buffer, pH 6.0, boiled for 20
minutes and cooled slowly. In case of phosphatase treatment, the sections were incubated with 400
mg/ml CIP for 19 hours at 32 °C [26]. Before staining the sections were blocked with Rodent Block
[Labvision] for 60 minutes. Slides were then incubated with culture supernatant of aS23NP, aS29NP
or TL pan- b-catenin diluted 1:100 in culture medium for 60 minutes. The primary antibody was
detected with Poly-HRP-Goat anti-mouse IgG [Immunovision] and DAB solution.
Luciferase reporter assays
5 x 10 5 293T cells were transfected using FuGENE 6 reagent [Roche] according to the manufacturer’s
recommendations. The cells were transfected with the following:
100 ng of luciferase reporter plasmid (either pTOP-Glow, containing three optimal Tcf binding sites
upstream of a TATA-box [19], or its negative control, pFOP-Glow, containing mutated Tcf binding
sites); 20 ng of pCMV-RNL encoding Renilla luciferase as an internal control for transfection efficiency
[Promega]; 300 ng of the â-catenin constructs and, where appropriate, pCi to equilibrate the amount
of plasmid DNA transfected. Cells were incubated for 24 h post-transfection prior to further analysis.
The Jurkat transfections were performed using 3 x 10 6 by electroporation with 50 ng Renilla, 0.5 mg
pTOP or pFOP-Glow and 2.5 ìg of the b-catenin constructs.Luciferase activities were determined using
the DUAL Luciferase Reporter (DLR) system [Promega] according to the manufacturer's protocol.
Reporter luciferase activity was normalised relative to Renilla-luciferase activity. Transfections were
performed in duplicate and three independent experiments were performed
Colony transformation assay
A 70% confluent 75 cm2 size culture flask of RK3E cells was transfected using FUGENE 6 with 6 mg of
the different b-catenin constructs. After 24 hours, the cells were plated into 6-well plates in dilutions
1:2, 1:4, 1:8 and 1:16. The cells were grown for 4 weeks, refreshing the media weekly. The
appearing colonies were stained with methylene blue in 1.5% para-formaldehyde and counted.
Results and Discussion
Aligning the N-termini of b-catenin homologues reveals several conserved
serines.
As b-catenin activity is regulated at its N-terminus, the N-termini of different
phylogenic homologues were aligned (Figure 1). This sequence alignment
revealed conservation of the four residues in b-catenin, that proposedly are
phosphorylated sites by GSK-3b: S33, S37, S45 and T41. In addition to these
serines and threonine, two other serines, S23 and S29, were also found to be
conserved (Figure 1).
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Figure 1. S23 and S29 are conserved within several b-catenin homologues. (A), the N-
terminal sequences of several b-catenin homologues are aligned; the conserved serines and
threonines are indicated in bold. (B), constructs harboring mutations found in tumors
In tumors, the CTNNB1 gene has extensively been sequenced for mutations in
the N-terminus of b-catenin, especially in the putative phosphorylation sites of
GSK-3â (Figure 1B). In addition to mutations in the known regulatory sites of
b-catenin, S29 has also been found mutated in two intestinal-type gastric
cancers [17], whereas S23 was reportedly mutated in a hepatocellular
carcinoma [16]. These reports, however do not state anything on the levels of
b-catenin present in these tumors. Mutations in these residues appear to be
rare events and the nature of these mutations was not discussed [16,17].
Nevertheless, since these serines are conserved, we hypothesized that S23 and
S29 might be involved in regulation of b-catenin activity.
Two mouse monoclonal antibodies that recognize the non-phosphorylated
serines aS23NP and aS29NP.
To further investigate S23 and S29, monoclonal antibodies were generated
against a bacterially produced peptide spanning the first 100 amino acids of b-
catenin. The epitopes of the individual monoclonals were crudely mapped using
N-terminal deletion constructs of b-catenin (WT, D19, D26 and D31) expressed
in Cos-cell transfections (data not shown). Epitopes of potentially interesting
clones were further mapped by PepScan analysis (Figure 2A, B). To investigate
whether the monoclonal antibodies are specific for the non-phosphorylated S23
and S29, peptide ELISA’s were performed with phosphorylated peptides
containing the serines of interest and their non-phosphorylated counterparts
(Figure 2C, D). We thus selected two hybridomas. The minimal epitopes of
aS23NP and aS29NP are RKAAVS23HWQ and HWQQQS29YLD respectively. The
antibodies only react when the pertinent serine residues are non-
phosphorylated.
The phosphorylation status of S23 and S29 is dependent on GSK-3b.
b-catenin activity is regulated through phosphorylation of the N-terminus by
GSK-3b. Down-regulation of GSK-3b activity, as seen upon Wnt signaling, can
be mimicked by treatment with LiCl, an inhibitor of GSK-3b [20]. To study
whether S23 and S29 are also phosphorylated in a GSK-3b-dependent fashion,
we determined whether LiCl could influence the phosphorylation status of these
serines. We selected the breast carcinoma cell line SKBR-3, which lacks both
alleles of E-cadherin [19] and therefore only contains the APC/Axin-bound
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signaling pool of b-catenin. Following LiCl treatment for 2 hours, SKBR-3 cells
activated Tcf/b-catenin mediated transcriptional activity as determined by a
transient reporter assay (Figure 3A). Western blotting revealed that total b-
catenin levels were elevated. The monoclonal antibodies, specific for the non-
phosphorylated residues S23 and S29 also revealed an increase in b-catenin
levels, following LiCl treatment. However, the fold increase detected by either
aS23NP or aS29NP was significantly greater than that observed with TL pan-b-
catenin antibody, which recognizes a C-terminal epitope and is insensitive to
the phosphorylation status of b-catenin (Figures 3 middle/bottom). The
increase of the levels detected by aS23NP or aS29NP were 2.7 and 2.5 fold
respectively. These results indicated that these residues are modified under
non-signaling conditions.
Figure 2. The characterization of aS23NP and aS29NP . The epitopes of aS23NP (A) and aS29NP
(B) were mapped by Pepscan analysis on 12 amino acid peptides. The scan ranges from amino acid 1
to 45 of the human b-catenin sequence. Vertical bars represent binding of the monoclonal to the
peptide. The sequences of the bound peptides reveals the minimal epitope. (C) and (D) Using
phosphorylated peptides in an ELISA assay, we established that the aS23NP and aS29NP antibodies
do not bind to their when phosphorylated
Following phosphorylation, b-catenin is ubiquitinated and thereby targeted for
degradation by the proteasome [12]. It is well established that the peptide
aldehyde ALLN (N-acetyl-Leu-Leu-norleucinal) inhibits proteasome mediated
degradation, resulting in accumulation of proteins metabolized by this pathway
[21]. To investigate the phosphorylation status of serines 23 and 29 in the
ubiquitinated pool of b-catenin, SKBR3 cells were treated with ALLN and cell
lysates analysed by Western blotting (Figure 3B, lane 3). As expected the TL
pan-â-catenin antibody detected the ubiquitinated b-catenin, which appeared
as a ladder above the prominent 92 kDa b-catenin signal. The aS23NP and
aS29NP stained the ladder of bands with significantly lower intensity relative to
the non-ubiquitinated b-catenin band. This indicates that the b-catenin pool
targeted for degradation has its S23 and S29 residues largely modified.
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Figure 3. GSK-3b  regulates phosphorylation of S23 and S29.  (A), SKBR-3 cells were transfected
with Top-Glow or Fop-Glow, followed by LiCl treatment. 20 mM LiCl treatment clearly enhances the
Top- luciferase activity. (B), Western blotting was performed on cell lysates of SKBR-3 cells, treated
with LiCl for 2 hours. The Western blot was incubated with the TL pan- b-catenin antibody, aS23NP
and aS29NP. The signal increases dramatically following LiCl stimulation. Note the signal in the lane of
the untreated cells. aS23NP and aS29NP also show a clear increase of signal following LiCl
stimulation. The fold increase of the stimulated versus the non-stimulated cells is higher with the
aS23NP and aS29NP antibodies compared to the TL pan-b-catenin antibody. ALLN treatment of the
cells, blocking the proteasome, shows a ladder of bands in the TL-pan- b-catenin antibody, whereas
the aS23NP and aS29NP antibodies detect these bands representing ubiquitinylated b-catenin to a
much lesser extent. (C), to confirm the presence of phosphate groups on S23 and S29 in vivo, 293T
cells were first treated with LiCL and ALLN and lysed. The protein samples were then treated with calf
intestine phosphatase (CIP). The CIP samples show a marked increase in signal with the aS23NP and
aS29NP antibodies, whereas the pan- a-b-catenin signal was unaffected by the addition of CIP.
We then sought to address whether S23 and S29 are phosphorylated in
vivo. 293T cells were treated with LiCl and ALLN, the cells were lysed and the
samples were dephosphorylated by the addition of calf intestine phosphatase
(CIP) for 5 minutes at 32oC. Subsequent Western blotting revealed that the
signal obtained with the pan-a-b-catenin antibody was not affected (Figure 3C,
upper panel). However, aS23NP and aS29NP showed markedly stronger bands
upon CIP treatment. Intensities of the bands obtained with the aS23NP and
aS29NP antibodies increased approximately 5 and 10 fold respectively, after
dephosphorylating the protein samples with CIP (Figure 3C, middle and lower
panel, lanes 1 and 4). As expected, differences induced by CIP treatment of
LiCl stimulated samples were not as obvious. In LiCl stimulated cells, the
majority of the b-catenin molecules are presumably already dephosphorylated.
The ALLN treated samples, however, did show increased signals particularly of
the high molecular bands (Figure 3 C, lanes 3 and 6). These data indicate that
the S23 and S29 residues are indeed phosphorylated in vivo.
Another question to be addressed was, if Wnt1 could also increase the levels of
b–catenin, which are unphosphorylated on S23 or S29. Therefore we
transfected 293T cells with Wnt1 or stimulated them with LiCl as a positive
control. The cells were allowed to grow for 24 hours and the cells were lysed
directly. Western blots were probed with the pan b-catenin antibody, aS23NP
and aS29NP. As observed with LiCl in SKBR3 cells, LiCl treating 293T cells,
result increased b-catenin levels and elevated levels of the non-phosphorylated
epitopes (Fig. 4 lane 2). Transfecting these cells with Wnt1 also increased the
total amount of b-catenin (Fig. 4 upper panel, lane 1 versus lane 3). Indeed,
also the specific antibodies revealed increased levels of the non-phosphorylated
epitopes (Fig. 4 middle and lower panel, lane 1 versus lane 3). Wnt signaling
controls the phosphorylation status of S23 and S29.
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Figure 4 Wnt influences the levels of
phosphorylation of S23 and S29. 293T cells were
transfected with Wnt1. Cell lysates were analyzed on
Western Blots and probed with the pan- b-catenin
antibody (upper panel), aS23NP (middle panel) and
aS29NP(lower panel).
S23/S29 phosphorylation during embryogenesis
Wnt signaling is essential for development throughout the animal kingdom.
Tight regulation of b-catenin levels during embryogenesis is therefore of great
importance. To know whether phosphorylation of S23 and S29 is regulated
during mouse development, we performed immuno-histochemistry on 12 day
old mouse embryos with aS23NP and aS29NP. These sections were compared
with sections stained with the TL pan-b-catenin antibody. aS23NP and aS29NP
yielded lower intensity staining whilst different tissues were differentially
reactive (Figures 5A and B,C). For instance, skin stained positive with TL but
was negative for aS23NP and aS29NP (Figures 5D, E and F). Figures 5F, G, H
provide an example of different staining in the central nervous system.
Whereas aS23NP and TL stain the adherens junctions, aS29NP fails to do so.
These results indicate that S23 and S29 are differentially phosphorylated
during mouse development. S29 is regulated more tightly, as non-
phosphorylated S29 appears to be not as widely distributed during mouse
development as non-phosphorylated S23. By dephosphorylating the paraffin
sections using CIP, staining intensities of the aS23NP and aS29NP readily
increased confirming that these epitopes are phosphorylated in vivo (data not
shown).
S23 or S29 mutations do not alter b-catenin’s co-transcriptional activity
The known phosphorylation sites of GSK-3b: S33, S37, T41 and S45 are
frequently mutated in tumors. If one of the usual residues is no longer
phosphorylated, the chain of events is broken: b-catenin is no longer
ubiquitinated and degraded. b-catenin will then accumulate, resulting in higher
transactivational activity. S23 and S29 have also been found mutated in
tumors. Therefore, mutations of these sites could also potentially enhance b-
catenin activity in reporter gene assays [22]. 293T cells were transiently
transfected with various b-catenin constructs (Figure 6A). Expression of b-
catenin forms with mutations in the known regulatory residues clearly
enhanced the transcriptional activity from the Tcf reporter TOP-glow relative to
wild type b-catenin. Unexpectedly, the transcriptional activity of the mutants
S23R and S29F was comparable to wild type b-catenin. Similar observations
were made in the T-lymphocyte cell line Jurkat (Figure 6B). Thus, in spite of
the fact that S23 and S29 are subject to GSK-3b phosphorylation, mutations in
these residues fail to result in dominant transactivating forms of b-catenin.
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Figure 5. S23 and S29 phosphorylation is regulated during embryogenesis. Day 12 mouse
embryos were stained with the different a-b-catenin antibodies. (A), (B) and (C) show the head region
of a day 12 embryo stained with TL-pan-catenin, aS23NP and aS29NP respectively. The antibodies
specific for the non-phosphorylated isoforms do not yield the ubiquitous expression patterns that the
TL pan- b-catenin antibody does. (D), (E) and (F), mouse skin of a day 12 embryo; the TL pan-b-
catenin antibodies readily detect the adherens junctions in the skin (arrows). With the aS23NP and
aS29NP antibodies, however, the skin does not stain. S23 and S29 are modified differentially as seen
in (G), (H) and (I). In membranous structures in the roof of the first ventricle, adherens junctions
stain with the TL-pan- b-catenin antibody and with aS23NP, but not with aS29NP.
Mutations in S23 or S29 are not transforming
Mutant b-catenin proteins are oncogenic, because they are resistant to
regulation by the GSK-3b/APC/Axin complex. Kolligs et al. have assessed the
oncogenic potential of wild-type and mutated forms of b-catenin. b-catenin
protein with the missense mutation S33Y efficiently induced neoplastic
transformation of RK3E cells [23]. Wild-type b-catenin however is not able to
transform this adenovirus E1A-immortalized epithelial cell line derived from
neonatal rat kidney. To asses the oncogenic potential of S23R and S29F, RK3E
cells line were transfected with various b-catenin constructs. As expected, wild
type b-catenin has a low transforming potential, whereas S33Y and S37A were
readily able to transform RK3E cells resulting in colony growth (Figure 7A).
Surprisingly, the S23R and S29F constructs did not show enhanced
transforming capacities upon transfection into RK3E cells compared to WT b-
catenin (Figure 7B).
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Figure 6. Mutations in S23 and S29 do not
alter the transcriptional activity of b-
catenin. (A), 293T cells were co-transfected
with the Tcf luciferase reporters, (TOP and FOP-
glow) and the indicated b-catenin mutants. 12
h post-transfection the cells were lysed and
their luciferase activity was determined. The
mutants S33Y, S37A, T41A and D45 show
elevated transcriptional activity compared to
WT b-catenin. S23 and S29, however, show
similar transactivation as WT b-catenin. (B),
transfection of Jurkat cells yielded the same
results, arguing against cell type-specific
effects.
Our current data identify two serine residues in the N-terminus of b-catenin
that are conserved between species, mutant forms of which are found in cancer
and whose phosphorylation status is controlled by GSK-3b. Yet the functional
significance of the mutations found in these residues as well as their regulated
phosphorylation remains unclear at present. The controlled phosphorylation
status of S23 and S29 could be explained by a bystander effect of promiscuous
phosphorylation on other more critical residues in the N-terminal region. The
fact that S29 is more readily phosphorylated might simply be explained by the
fact that S29 is nearer to the known regulatory serines then S23 and thereby
more likely to be included in the phosphorylation process. Another explanation
for the fact that S29 is phosphorylated more frequently could be due to spacing
of the putative phosphorylation sites of GSK-3b. The known serines S33, S37,
T41, and S45, but also S29 are four amino acids apart, in contrast to S23,
which is 6 amino acids upstream of S29. Thus, GSK-3b might not be able to
phosphorylate S23 as efficiently as S29. The phosphorylation status of S23 and
S29 is not anticipated to influence binding of interacting proteins as the known
binding partners of b-catenin bind to the armadillo repeats or to the C-terminal
part of b-catenin [24,25]. It remains possible, though, that the S23 and S29
residues do perform a function which is not unveiled in the reporter assay or
the focus formation assay, yet are critical for b-catenin’s in vivo signal
transduction capacity during development or carcinogenesis. Such a role can
only be addressed by in vivo manipulation strategies such as gene knock-in
into the mouse germ line.
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Figure 7. S23 and S29 show no enhanced transformation capacity. RK3E cells were transfected
with the various b-catenin constructs. After four weeks, colonies were counted. (A), a typical colony
growing through confluency . (B), b-catenin mediated transformation. The known oncogenic mutants
S33Y and S37A show enhanced transforming activities, whereas S23R and S29F do not induce colony
formation.
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The Wnt-signaling pathway is one of the important cascades in the
embryogenesis of animal species, vertebrate and non-vertebrate. The
regulation of b-catenin levels is the key regulatory steps in this cascade. In
cells devoid of Wnt signals, b-catenin levels are kept low due to
phosphorylation by GSK-3b. This phosphorylated b-catenin is specifically
recognized by b-TrCP, which guides the protein to the ubiquitination machinery.
Ubiquitinated b-catenin is rapidly degraded in the proteasome. Wnt-signals lead
to the inhibition of GSK-3b, resulting in increased levels of b-catenin.
Chapter 2 describes the development of a monoclonal antibody against the
non-phosphorylated form of b-catenin. This antibody called aABC was well
characterized by mapping with deletion constructs, Pepscan analysis, and
phosphopeptide ELISA’s. With this antibody we could finally prove a strongly
held but never proven belief, that Wnt signaling leads to the accumulation of
non-phosphorylated b-catenin. By calf-intestine phosphatase treating of cell
lysates we could also finally prove that phosphorylation occurs and precedes
ubiquitination, another issue which nobody will dispute, but never has been
shown with experimental data. In mouse development Wnt signaling is of great
importance. Knock out mice have shown that Tcf’s are required for the proper
development of the intestine (Korinek et al., 1998), T-cell differentiation
(Verbeek et al., 1995) and the formation of several ectodermal derived
structures (van Genderen et al., 1994;Galceran et al., 1999). With the aABC
antibody we could confirm these findings as we could detect active signaling b-
catenin for instance in the crypts of the developing intestine, hair follicles,
mammary gland formation, and tooth buds. As every cell expresses more then
one Tcf/Lef and Tcf/Lef’s act as repressors as well as activators, Tcf/Lef-/- mice
will not reveal all organ systems the canonical Wnt pathway is involved in. The
Wnt-phenotypes pose the problem of distinguishing between the canonical and
the non-canonical Wnt pathway. Therefore the a-ABC is likely to add more
information regarding the importance of the canonical Wnt signaling during
mouse embryogenesis and will prove to be an important tool in studying
development.
In chapter 3 we show that accumulation of b-catenin levels per se is not
sufficient for signaling. As in several tumors b-catenin mutations have been
found in the four putative GSK-3b phosphorylation sites, it seemed logical that
the phosphorylation status could be important for the transactivational activity
of b-catenin. To address the question if indeed dephosphorylated b-catenin is
required to mediate Wnt-signals to the nucleus, we generated antibodies
against the N-terminus of b-catenin. The goal was to find a monoclonal specific
for the N-terminally non-phosphorylated form of b-catenin (aABC). The
characterization of this monoclonal antibody is described in more detail in
chapter 3. With aABC we could demonstrate the necessity of N-terminally
dephosphorylated b-catenin for gene transcription. Accumulating b-catenin by
preventing its breakdown lead to the increase in total b-catenin levels, but the
transcriptional activity as monitored by the TOP/FOP reporter assay remained
low. Increasing b-catenin levels by transfecting Wnt-1 or S33 b-catenin
resulted in increased reporter gene activity, as did treating the cells with LiCl.
Western blot analysis of these samples with the a-ABC antibody showed a clear
correlation between luciferase activity and the immunoreactivity of aABC.
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Our data contradict experiments where the ubiquitination of b-catenin was
halted by transfecting a dominant negative form of b-TrCP. This resulted in
enhanced reporter gene activity. As this accumulated pool of b-catenin in
theory is phosphorylated, these findings are in sharp contrast to our data in
chapter 3 (Hart et al., 1999). Speculating on reasons for these contradictory
data, one might think that b-TrCP functions as an anchor for b-catenin.
Blocking proteasome activity or the ubiquitination would then result in
phosphorylated b-catenin in the vicinity of the ubiquitination machinery and
thereby keeping it away from the transcriptional machinery. As the DF-box
mutant of b-TrCP lacks the interaction domain for the ubiquitination complex,
b-catenin could reach the transcription machinery again, resulting in reporter
gene activity. It would be interesting to transfect a b-TrCP mutant lacking the
WD40 repeats, which is unable to bind b-catenin (Hart et al., 1999;Liu et al.,
1999). This would result in accumulation of phosphorylated b-catenin, which
should not be able to induce reporter gene transcription.
Another possibility could be that phosphorylated b-catenin is unable to interact
with either nuclear import proteins or transcription factors, due to the
enhanced negative charge or the N-terminus. The F-box mutant would then
shield of the negative charge restoring the interactions required for
transcription. The strong transactivational capacity of the b-catenin mutant
lacking the complete N-terminus, could be explained by both hypotheses. To
investigate the anchor hypothesis, localization studies of b-TrCP and the F-box
mutant with b-catenin were done, but as b-TrCP is predominantly expressed in
the nucleus, it was impossible to show differential localization between WT b-
TrCP and the F-box mutant (data not shown).
The canonical Wnt signaling pathway is not only required for development. In
many tumors originating from different species mutations have been described
in several components of the pathway. Wnt-1, the founding member of the Wnt
family, was originally cloned from virus transformed mammary tumor cells.
APC mutations are causative for 100-1000 polyps found in familial
adenomatous polyposis coli patients, though also 80% of the sporadic
coloncarcinomas have mutations in the APC gene. These mutations result
mostly in truncated proteins which are no longer able to bind b-catenin and
sequester it in the large cytoplasmic complex, required for phosphorylation and
degradation. Hence dephosphorylated b-catenin accumulates and constitutively
active b-catenin/Tcf complexes result in overexpression of target genes.
Carcinomas originating from several tissues show involvement of Tcf/b-catenin
signaling. In chapter 4 we set out to investigate the possibilities of using the
aABC antibody to detect b-catenin mediated signaling on human (tumor)
tissue. After establishing this, we continued by investigating the presence of
active signaling b-catenin in human mammary tumors. In 70% of these
carcinomas aABC signal was detected in the nuclei of the tumor cells. However,
the presence of aABC signal could neither be correlated to the tumor type, the
differentiation grade, the mitotic index, the invasiveness of the tumor nor the
E-cadherin expression. Nevertheless these data show not only that the aABC
antibody can be useful to determine the involvement of Tcf/b-catenin mediated
signaling, also the involvement of these proteins in breast carcinoma
pathophysiology.
One striking observation made with the aABC antibody, was that the majority
of the b-catenin in the adherence junctions is phosphorylated. As
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phosphorylated b-catenin is degraded at a high rate, this observation was
unexpected. Speculating on the meaning of  these observations, the idea rose
that maybe b-catenin, required for the adherence junctions, is targeted for
transport to the plasma-membrane directly after its production. This targeted
b-catenin could be phosphorylated but protected for degradation by a
chaperone protein. As soon as these molecules participate in the highly stable
complexes, the degradation complex could no longer capture b-catenin. It is
not difficult to imagine that as high levels of b-catenin are present in the cell,
these molecules are phosphorylated. If this pool of b-catenin was freed from
the adherence junctions, the molecules would be targeted for degradation. It is
not surprising that cells are protected for high levels of potentially such a
dangerous protein. These speculations result in the hypothesis that under
physiological circumstances the pools of b-catenin responsible for cell-cell
adhesion and signaling are completely separated. The observation that breast
tumor cell lines lacking E-cadherin expression rarely show elevated reporter
gene levels support this hypothesis (van de Wetering et al., 2001).
In chapter 5 we tried to investigate the mechanisms involved in b-catenin
phosphorylation by GSK-3b. Though the list of participants in the Wnt-signaling
pathway continues to lengthen, until now no phosphatase of b-catenin has
been cloned. Therefore we wanted to address the question, whether
phosphatase activity is required or that b-catenin needs to be newly
synthesized in order to accumulate and transactivate. Experiments with
cyclohexamide and stimulation with LiCl clearly showed that b-catenin
accumulation requires de novo synthesis. In the presence of cyclohexamide,
LiCl is not able to induce the presence of dephosphorylated b-catenin. These
results indicate that there is no constitutively active phosphatase present.
Nevertheless Wnt signaling could induce phosphatase activity to
dephosphorylate b-catenin. These data also imply that the turn-over rate of b-
catenin must be very high, otherwise it would take considerable time to
accumulate dephosphorylated b-catenin upon a Wnt-signal. The half life of b-
catenin has been estimated to be around 4 hours (Guger and Gumbiner, 2000),
which contradicts our assumption. The half life, however, has been determined
in cells containing E-cadherin. The majority of the b-catenin molecules are
located in these stable complexes, therefore this pool will considerably
lengthen the half life. In E-cadherin lacking SKBR-3 cells, the signaling pool of
b-catenin can be studied in more detail (van de Wetering et al., 2001). LiCl
treatment of these cells for during different time spans lead to an estimated
turn over rate of approximately 15 minutes. This supports the idea that b-
catenin is rapidly accumulated due to de novo synthesis.
Recently the crystal structure of the kinase has been resolved (Dajani et al.,
2001;ter Haar et al., 2001). GSK-3b not only participates in the Wnt-signaling
pathway, it phosphorylates many substrates. The mode of phosphorylation of
these substrates seem to differ from the phosphorylation of b-catenin, axin and
APC. Phosphorylation of glycogen synthase requires phosphorylation of the +4
position before GSK-3b phosphorylates its substrate. This primed
phosphorylation is not thought to be the mechanism whereby b-catenin is
phosphorylated as FRATide peptides impair the phosphorylation of glycogen
synthase, whereas b-catenin phosphorylation is not altered. FRATide peptides
inhibit the primed phosphorylation, in contrast to unprimed phosphorylation.
Hence, the conclusion was drawn that b-catenin phosphorylation was unprimed.
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To address this issue we transfected mutants in the serines and threonine
within the GSK-3b phosphorylation site and monitored the phosphorylation
status of S33 and S37/T41. If unprimed phosphorylation would be the mode of
action, the phosphorylated status should not be influenced by mutations in the
other serines, but our data show clearly that if one of the serines is mutated
the others are unphosphorylated as well. This would rule out the possibility of
unprimed phosphorylation When we wanted to investigate the relative order of
phosphorylation, we expected to find the necessity of a phosphate at the +4
position as described for glycogen synthase. We could show clearly that upon
introducing a mutation at the S45 postition none of the other phosphorylation
sites could be phosphorylated. However, a mutation at the S33 postition did
not alter the phosphorpylation status of S37, indicating that the
phosphorylation events start at S45 moving upstream. The phosphorylation
recognition site for GSK-3b is SxxxSxxxSxxxS (Park et al., 1999). The fact that
mutations in between the serines are also resulting in dominant positive forms
of b-catenin could be due to diminshed binding of b-TrCP to phosphorylated b-
catenin or decreased efficiency of phosphorylation by GSK-3b. As glycogen
synthase phosphorylation by GSK-3b is primed by another kinase, casein
kinase 2, it is likely that a priming kinase also exists for b-catenin (Picton et al.,
1982; Woodgett and Cohen, 1984). Finding this kinase will contribute to the
understanding of the mechisms underlying b-catenin phosphorylation to a great
extend.
In chapter 6 we describe the presence of two additional serines in the N-
terminus of b-catenin, which are conserved if sequences of b-catenin
orthologues are aligned. In literature mutations were also found in these
serines, S23 and S29, though not frequently. This lead to the assumption, that
these residues might be involved in b-catenin regulation as well. The
phosphorylation status of these serines were regulated by GSK-3b, as LiCl
treatment resulted in dephosphorylated residues as shown with antibodies
specific for the non-phosphorylated S23 and S29. These antibodies also clearly
showed that the phosphorylation status of these residues is regulated during
development. However, substituting the serines with the mutations found in
tumors, did not result in higher transactivation. These mutant molecules were
also not able to transform RK3E cells. So the function of these conserved and
regulated serines still remains unresolved. Mutating these residues however,
did not affect the phosphorylation of S33, S37, and T41 (data not shown).
Song et al. described the phosphorylation of b-catenin by CK2 on serine 29
(Song et al., 2000). Inhibition of CK2 results in accelerated degradation of b-
catenin, which would suggest that active signaling b-catenin would be
phosphorylated on S29 and b-catenin targeted for degradation would by un-
phosphorylated. These data are in sharp contras to what we observe in SKBR-3
cells. Inhibition of GSK-3b activity results in a signaling active pool of b-catenin
which is dephosphorylated on S29. Blocking the proteasome accumulates b-
catenin pools, which are normally targeted for degradation. These b-catenin
molecules are phosphorylated to a large extend on S29. It seems that the
regulation of this site resembles the regulation of the known GSK-3b sites.
In conclusion, we showed that N-terminally non-phosphorylated b-catenin is
required for Wnt signaling. The aABC, aS23NP, and aS29NP monoclonal
antibodies are useful tools to investigate the activity of the canonical Wnt
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signaling pathway and to address questions regarding the mechanisms
involved in the regulation of the transcriptional activity of b-catenin, some of
which we tried to address. When in course of time compounds will be found to
inhibit the activity of  Wnt signaling, aABC potentially could become useful in
detecting the involvement of b-catenin/TCF mediated signaling in patient
material. This thesis fills in some of the gaps in b-catenin regulation. The aABC
antibody will contribute to solving many other questions regarding Wnt
signaling in development and carcinogenesis.
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Niet gefosforyleerd b-catenine in Wnt-signalering
De ontwikkeling van een compleet organisme vanuit een enkele cel is een
uiterst ingewikkeld en nauwkeurig gereguleerd proces. Nu pas beginnen we
een klein deel van het proces te begrijpen. Waar het uiteindelijk allemaal om
gaat is dat, zowel op de juiste plek als op het juiste tijdstip, cellen de juiste
eiwitten maken. De genetische informatie van alle eiwitten ligt opgeslagen in
het DNA en wel in de celkern van iedere cel. Een cel heeft niet alle eiwitten
nodig en zal daarom maar een gedeelte, de zogeheten subset produceren. De
samenstelling van deze subset bepaalt zowel het uiterlijk, als de functie van de
cel. Signaaltransductie cascades (signaal doorgeef routes) bepalen welke
eiwitten wel en welke niet van het DNA worden afgeschreven. Dit doen ze door
het signaal vanaf de buitenkant van de cel, via eiwiteiwit interacties, door te
geven aan de celkern. Het signaal wordt als het ware als een estafettestokje
doorgegeven van eiwit naar eiwit. In de celkern zorgt de “laatste loper”, de
transcriptiefactor (een aan/uitschakelaar voor genen) voor het
herprogrammeren van de cel, die zo de subset genen die gebruikt wordt
aanpast aan het inkomende signaal.
In dit proefschrift speelt de Wnt-cascade een belangrijke rol en daarvan is
inmiddels duidelijk, dat zij tijdens de ontwikkeling van alle organismen van
immens groot belang is. Deze cascade begint met Wnt, een uitgescheiden eiwit
dat zich via en tweetal receptoren (ontvangers) aan een cel bindt, met als
gevolg dat het eiwit b-catenine stapelt en het estafettestokje naar de celkern
brengt. In een niet-signalerende cel, een cel die geen Wnt krijgt, wordt b-
catenine afgebroken d.m.v. het ingewikkelde samenspel van meerdere
eiwitten. Een van die eiwitten is APC, dat geïdentificeerd werd bij familiaire
dikke darm kanker patiënten. APC is een zogenaamde tumorsuppressor gen.
Als beide genen defect zijn, door fouten in het DNA, dan ontstaan er in de
dikke darm duizenden poliepen, waarbij een van deze poliepen zich steevast
tot kanker ontwikkeld. Daar zijn nog meer fouten in het DNA voor nodig, maar
door de ongeremde groei gaat dat haast als vanzelf. Het eiwit b-catenine heeft
twee uiterst verschillende functies. Ten eerste speelt b-catenine een rol in de
adherence junctions, zeer gespecialiseerde structuren die cellen aan elkaar
bevestigen, ten tweede speelt b-catenine dus een rol in de Wnt-cascade. Op de
eerste rol zal verder niet worden ingegaan, hoewel deze tweedeling het
bestuderen van het eiwit wel moeilijker maakt.
Zoals beschreven stapelt b-catenine zich als de Wnt-cascade in werking wordt
gezet en gaat vervolgens naar de celkern waar het een interactie aangaat met
de transcriptiefactor T-cell factor (TCF). In een cel waar geen Wnt-signalering
plaatsvindt, wordt b-catenine weliswaar aan de lopende band geproduceerd,
maar wordt ook meteen weer afgebroken. Het eiwit wordt als het ware
gebrandmerkt door er fosfaatgroepen aan te hangen (fosforyleren). Dit
gefosforyleerd b-catenine wordt herkend door eiwitten die op hun beurt b-
catenine ubiquitineren (er een ubiquitine groep aanhangen). Ubiquitine is een
overal (ubiquitair) voorkomend klein eiwit. Geubiquitineerde eiwitten worden
direct afgebroken door het proteasome, een “eiwit versnipperaar”. b-catenine is
belangrijk bij de ontwikkeling van colonkanker (dikke darm kanker) en andere
tumoren (gezwellen). De oorzaak van colonkanker is in 95% van de gevallen
stapeling van b-catenine, terwijl er geen Wnt-signalering is. Dit komt doordat
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er mutaties (veranderingen) optreden in de b-catenine zelf, of in één van de
eiwitten die betrokken is bij het fosforyleren hiervan en waardoor b-catenine
niet meer kan worden afgebroken. In de meeste gevallen handelt het zich om
mutaties in het eerder beschreven APC gen. Door deze mutaties wordt het eiwit
korter en kan het geen interactie meer aangaan met b-catenine. De mutaties
die in b-catenine zelf worden aangetroffen zijn gelokaliseerd in de sequenties
(volgorde) die gefosforyleerd worden, dit voorkomt dus fosforylatie,
ubiquitinatie en afbraak.
Stapeling van b-catenine werd in de literatuur beschreven als een belangrijke
en een nauwkeurigst regulerende stap binnen de cascade. Wij konden echter
aantonen dat stapeling alleen niet genoeg was voor signalering. Door, na de
fosforylatie, de afbraak van b-catenine te blokkeren, stapelden cellen b-
catenine op een onnatuurlijke wijze. Deze moleculen konden niet meer leiden
tot het aanzetten van genen. Wij besloten tegen het stuk van b-catenine, dat
normaliter wordt gefosforyleerd, een antilichaam (herkenningseiwit) te maken.
Dit antilichaam of antistof wordt gemaakt door muizen met het eiwit van
belang te immuniseren (kunstmatig opwekken van immuniteit tegen het eiwit
van interesse) en daarna de B-cellen te isoleren. Deze B-cellen zijn de witte
bloedlichaampjes die voor de antilichaam productie verantwoordelijk zijn.
Iedere B-cel maakt een andere antistof, zodat het organisme tegen een grote
verscheidenheid van pathogene (ziekteverwekkers, bijv. Bacteriën en virussen)
beschermd is. De B-cellen van de ingespoten muis worden vervolgens
onsterfelijk gemaakt en getest op de specificiteit van het antilichaam dat ze
produceren. Antistoffen worden gebruikt om eiwitten voor het oog zichtbaar te
maken op bijv. coupes (dunne schijfjes) van weefsels.
Uiteindelijk ontwikkelden wij een antilichaam dat alleen de niet gefosforyleerde
b-catenine moleculen op twee bepaalde aminozuren, S37 en T41, herkent dat
aABC werd gedoopt. Natuurlijk was dit niet het enige antilichaam dat we
hebben gemaakt, twee anderen komen later nog ter sprake. Met aABC konden
twee belangrijke openstaande vragen worden beantwoord. Ten eerste toonde
het aan dat Wnt signalering tot stapeling van niet-gefosforyleerd b-catenine
leidt. Ten tweede maakte het antilichaam duidelijk dat alleen niet-
gefosforyleerd  b-catenine in staat is om het signaal, dat door Wnt wordt
aangestuurd, naar de celkern door te geven. Dus is de fosforylatiestatus (de
aan- of afwezigheid van een fosfaatgroep) van b-catenine niet alleen van
belang om niet te worden afgebroken, ook de transcriptionele activiteit wordt
hierdoor beïnvloed. aABC herkent dus specifiek de signalerende vorm van b-
catenine. Dit maakt aABC tot een uiterst nuttig gereedschap om te
onderzoeken waar Wnt signalering actief is. Het was dan ook erg belangrijk dit
antilichaam goed te karakteriseren en analyseren, hetgeen met name in
hoofdstuk 2 wordt beschreven. Een opvallend aspect van deze antistof is, dat
het de b-catenine moleculen die betrokken zijn bij de cel-cel contacten niet
aankleurt. In hoofdstuk 3 wordt de aandacht gevestigd op de stapeling van b-
catenine en de correlatie (onderlinge samenhang) tussen de niveaus van
ongefosforyleerde b-catenine en de signalerende activiteit van het eiwit.
In hoofdstuk 4 gebruikten wij aABC op patiënten materiaal. Door zowel de Tcf-
4 “knock-out” muis (dit is een muis waar het Tcf-4 gen is verwijderd) als de
colontumoren weten we dat Wnt signalering in de ontwikkeling van de darm
________________________________________________Nederlandse Samenvatting
103
een belangrijke rol speelt, vooral in de crypten (holtes), waar celdeling
plaatsvindt. Dat we actief b-catenine in de crypten konden aantonen was nu
geen verrassing meer, maar leidde tot de volgende stap: konden we nu ook
overactief b-catenine in borsttumoren aantonen? Waarom hebben wij voor
borsttumoren gekozen? Wnt1 is oorspronkelijk ontdekt in muizenborsttumoren,
dus was er een reële kans tumoren te treffen waar Wnt signalering van belang
is. Alhoewel gezond borstweefsel negatief bleek voor de aanwezigheid van
signalerend b-catenine, vertoonden 70% van de geteste borsttumoren wel een
verhoogde hoeveelheid signalerend b-catenine. Helaas was er geen verband
tussen de aanwezigheid van een aABC signaal en het type, de
differentiatiegraad of de agressiviteit van de tumor.
Hoofdstuk 5 behandelt de mechanismen die bij de fosforylatie van b-catenine
zijn betrokken. De eerste vraag die moest worden beantwoord was, of b-
catenine actief gedefosforyleerd wordt, of dat de gestapelde moleculen nieuw
gesynthetiseerd (gemaakt) moeten worden. Het laatste bleek het geval,
hetgeen nog al verrassend was, daar b-catenine heel stabiel is en bovendien
een lange halfwaardetijd (dit is de tijd waarin een vaststaande hoeveelheid
eiwit gehalveerd wordt) heeft. Door de eerdergenoemde dubbele functie zou dit
wel eens tot een vertekend beeld kunnen leiden, hetgeen betekende dat we,
alleen voor de signalerende b-catenine, nogmaals de halfwaardetijd bepaalden.
Hierbij kwamen we uit op 17 minuten, wat betekent dat b-catenine heel snel
geproduceerd en afgebroken wordt. Vervolgens zijn wij dieper ingegaan op de
rol van verschillende mutaties in de fosforylatie sequenties (de
aminozuurvolgorde die gefosforyleerd worden) van b-catenine en werden
hiervoor in die vier verschillende sequenties mutaties aangebracht. Het
belangerijkste aminozuur binnen deze sequenties is een serine of een
threonine. Er werden twee soorten mutaties aangebracht, enerzijds mutaties
die bij tumoren zijn aangetroffen, anderzijds mutaties die negatief geladen zijn.
Aangezien fosfaatgroepen ook negatief geladen zijn, wordt er verondersteld dat
deze mutaties fosforylatie kunnen nabootsen. Het bleek dat deze nabootsing bij
b-catenine niet werkt bij de twee buitenste fosforylatiesequenties. Een
verklaring hiervoor hebben wij niet, maar het betekent wel dat de verschillende
fosforylatiesequenties een andere taak hebben. b-catenine wordt gefosforyleerd
door het eiwit GSK-3b, dat ook andere substaten (doeleiwitten) heeft. Van die
andere eiwitten was bekend dat de fosforylatie in een bepaalde volgorde
geschied en dat een andere kinase (fosforylatie-eiwit) eerst een fosfaatgroep
moet koppelen. Van b-catenine dacht men dat die volgorde niet van belang was
en een dergelijke kinase niet bestond. Met aABC en een aantal andere b-
catenine specifieke antistoffen konden wij aantonen dat er wel degelijk sprake
is van een bepaalde volgorde.
In het laatste experimentele hoofdstuk berichten wij over twee extra
fosforylatiesequenties in b-catenine en onderzoeken wij welke rol deze spelen
in de regulatie van de functie van b-catenine. Deze sequenties zijn
geconserveerd (behouden gebleven) tussen de fruitvlieg, de muis, een aantal
sponzen en de mens. Dit geeft gewoonlijk aan dat deze sequenties dus van
belang zijn, anders zou de natuur er gedurende de evolutie niet zo zuinig op
zijn geweest. Ook waren er in de literatuur berichten over mutaties in deze
sequenties. Bij het ontwikkeling van aABC maakten wij ook antistoffen die
specifiek waren voor niet-gefosforyleerd serine 23 en 29. Deze werde a-S23Np
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en a-S29NP genoemd. Met deze antistoffen konden we laten zien dat Wnt
signalering de fosforylatiestatus bepaalt. Ook is de status nauwkeurig
gereguleerd tijdens de embryonale ontwikkeling, zoals zichtbaar op coupes
van dag 16 muizenembryo’s. Vervingen wij echter de serines met de mutaties
aangetroffen bij tumoren, werd de transcriptionele activiteit van b-catenine niet
groter. Ook konden deze mutaties cellen niet transformeren (onsterfelijk
maken) zoals mutaties in de bekende fosforylatiesequenties wel kunnen.
Hierdoor blijft de functie van deze nauwkeurig gereguleerde sequenties
raadselachtig.
Dit proefschrift is voornamelijk gebaseerd op het maken van zeer specifieke
antistoffen en de experimenten die hiermee mogelijk zijn. aABC is als
gereedschap “one of a kind”, waarmee in de toekomst zeker nog vele vragen
beantwoord kunnen worden. Een baanbrekend aspect hiervan is de
mogelijkheid om aABC in de klinische diagnostiek te kunnen gebruiken. Mocht
er een geneesmiddel worden ontwikkeld om b-catenine/Tcf te kunnen remmen,
is aABC bij uitstek geschikt om patiënten op te sporen voor wie dit
geneesmiddel zou kunnen werken. Met de ontwikkeling van deze
geneesmiddelen is men druk doende en er zijn sterke aanwijzingen dat het
voorkomen van de samenwerking tussen b-catenine en Tcf voldoende is om
cellen weer in het gareel te krijgen. Dit biedt hoop voor de toekomst!
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Een woord van dank....
Laatst had ik het er nog met Wim over: volgens velen was het schrijven van
het dankwoord het moeilijkst van het hele proefschrift. Daar ben ik het niet
mee eens, het enige waar ik bang voor ben is dat ik iemand vergeet. Daarom
wil ik beginnen om iedereen te bedanken die op welke manier dan ook heeft
geholpen bij het tot stand komen van dit boekje. Vooral alle mensen van
Clevers lab, degenen die er nu rond lopen, maar zeker ook degenen die het lab
inmiddels al weer hebben verlaten. Jullie zijn met zijn allen echt fantastisch
geweest. Ik heb niet alleen op technisch vlak veel geleerd maar we hebben ook
ontzettend veel plezier gehad. Dear non-Dutch colleagues, thanks for
everything, the good times and the assistance in any possible way. You guys
were great!!
Toen ik begon bestond het lab uit 18 mensen, nu lopen we tegen de 30. Dit
houdt in dat we meer rekening met elkaar moeten houden en dat is niet altijd
even makkelijk. De regelmatige ergernis als er weer lege dozen in de kast
staan, de pipetladen leeg zijn en de weegkamer te vies is om in af te wegen,
weegt echter niet af tegen de positieve kanten. Een ieder, met zijn/haar eigen
karakter en ervaringen (en dus kennis), levert een unieke bijdrage aan het
Clevers lab. Ik hoop dat dat nooit verandert!!!
Maar er zijn natuurlijk een aantal mensen die ik nog eens extra wil bedanken.
Allereerst mijn ouders, Ad en Mieke, en niet alleen omdat jullie de moed
hebben gehad om mij op de wereld te zetten. Jullie hebben altijd in mij
geloofd, vanaf kleins af aan. In Oostenrijk, bij voorbeeld, mochten ze me geen
klas terug zetten, dat kon altijd nog als het echt niet ging. En dat terwijl we
pas 9 weken in Hinterbrühl woonden, toen ik voor het eerst naar school moest.
Jullie hebben altijd vierkant achter mij en mijn beslissingen gestaan, ook al
deed dat soms pijn. Lieve pap, sinds mijn eerste promotiedatum vast stond
heb jij me gemotiveerd door je serie “promoveren”. Je korte verhalen zijn
fantastisch en alle andere verrassingen waren geweldig, waarvan ons uitstapje
naar Körperwelten zeker niet de minste was. Die avond heb ik zelfs met stokjes
leren eten. Je zou eens moeten overwegen de verhalenbundel naar een
uitgever te sturen!! Mam, ik heb het idee dat jij ook je steentje wilde
bijdragen, vooral toen het even echt stressy was, maar dat je het gevoel had
dat je daarin tekort schoot. Het tegendeel is waar, onze telefoontjes waren een
bron van energie, zodat ik er daarna weer tegen aan kon en de saunatripjes
onvergetelijk, om van de carnaval maar niet eens te spreken. Jullie nimmer
aflatende moeite om echt te proberen te begrijpen waar ik nou mee bezig
was/ben, is een groot compliment waard.
Hans, ik wil jou bedanken voor de kans die je me hebt gegeven, ondanks dat ik
bij Marcel stage had gelopen. Ik hoop dat ik bewezen heb, deze kans waard
geweest te zijn, al ging het niet altijd van een leien dakje. Jouw snelle denken
en de kunst om zo razendsnel verbanden te leggen hebben mij altijd weer
versteld doen staan. Het was dan ook een streven jou één keer een stap voor
te zijn. Dit streven heeft geleid tot hoofdstuk 6, een hoofdstuk waar ik extra
trots op ben. Ik wil je absoluut geen veer in je …. stoppen, maar ik denk dat de
Catharijne Prijs en de Spinoza Premie eindelijk jou nationaal de erkenning
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geven die je internationaal al genoot. Het was zeer leerzaam bij jou te mogen
promoveren. Al moest ik je soms achter je …. aan zitten om mijn proefschrift
op tijd naar de commissie te kunnen sturen. Ik hoop dat het werk e de grootte
van het lab je niet boven het hoofd gaat groeien, zodat je regelmatig kan
blijven meegenieten van Evil Dick en zijn kornuiten.
Marc en Frank, mijn twee officieuze copromotoren. Jullie zouden niet meer van
elkaar kunnen verschillen, maar in een ding zitten jullie op een lijn: Zonder
jullie steun in moeilijke tijden, technische adviezen en gezelligheid, had ik het
waarschijnlijk niet gered. Frank, jij bleef in me geloven toen ik het zelf niet
meer deed. Gedurende het diepste dal waar iedere AIO kennelijk doorheen
moet, bleef je me aanmoedigen. Zo te zien heb je gelijk gekregen: Behalve een
gezamenlijke paper, is het nu dan toch zover, ik heb het wèl gered. Ik zie dan
ook met veel plezier uit naar de komende twee jaar weer samen werken met
jou. Marc, jij nam moeiteloos de taak over toen Frank naar Rotterdam ging. Je
bent de spil van het lab, hopelijk blijf je het zo naar je zin hebben als je me
laatst vertelde. Nog bedankt voor de prachtige roos, trouwens. En verlies
alsjeblieft nooit je gevoel voor humor…als ik maar nooit meer mee achter op de
motor hoef!
Moniek en Helen, mijn twee nimfjes, jullie maakten het een berengezellige tijd.
Moniek, jij nam me op sleeptouw toen ik net op het lab kwam. Van
eiwitzuiveringen in de eerste week tot het regelwerk rond mijn promotie in de
laatste maanden, jij stond altijd voor mij klaar. Toen je naar Oncologie
verhuisde, vluchtte ik regelmatig even naar de derde om bij te kletsen en mijn
hart te luchten. En volgens mij ben ik nog niet eens op de helft van je
boekenkast. Veel geluk met je inmiddels eigen groepje en natuurlijk straks met
de kleine. Helen, ons chaootje, jij begon een maand eerder dan ik, dus we
liepen regelmatig tegen de zelfde problemen aan. Je hebt een zware tijd achter
de rug, maar je leventje schijnt nu op alle fronten in rustiger vaarwater te
belanden. Ik hoop van harte dat deze trend zich ook gaat doorzetten in je
werk. Want we hadden samen naar onze promotie moeten toeleven, maar
helaas heb je nog ruim een jaar te gaan. Dat het bij jou dadelijk opeens net zo
moge gaan vlotten als bij mij. Hou vol, hè!! Meiden, hopelijk is onze
vriendschap ook bestand tegen grotere afstanden. We zullen gewoon
regelmatig onze agenda’s (!!) moeten trekken!
Adam and Rachel, two of my native English-speaking colleagues, I want to
thank you both for the endless corrections on the papers and chapters of my
thesis. That must have been a hell of a job. Adam, you are also the “nar” of our
lab, don’t you ever change!! Rachel, jou kan ik net zo goed in het Nederlands
bedanken, want dat is bijna “spotless”.
Annette, mijn achterbuurvrouw, mevrouwtje Baas, we hebben samen heel wat
blotjes besproken en ideeën uitgewisseld. Je kwam op een totaal ander
onderwerp terecht dan de rest van ons. Brainstormen over je resultaten was
dan ook een hele opgave, maar wel elke keer weer leuk om te doen. Ik ben
heel benieuwd hoe het verder gaat lopen met je promotie. Succes!! Wie weet
kunnen we samen een keertje aan een of ander toernooitje meedoen.
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Natuurlijk wil ik Wim bedanken voor het als maar weer luisteren. Jouw
gastenstoel stond er niet voor niets. Jij hebt ook 4 turbulente jaren achter de
rug en gelukkig kon je ook je verhaal bij ons kwijt. Vaak genoeg heb je nog
een uitgelopen experiment voor me afgemaakt, zodat ik de volgende dag weer
met een nummertje 2 moest komen opdraven. Vergeet niet, dat als Hans je
weer eens pest met je gebrek aan richtingsgevoel, hij het verschil tussen Oost
en West niet kent.
Petra en Karin, van de vroege garde. Hans is menigmaal weer omgedraaid als
hij ons met Moniek zag kletsen over recepten en zo. We hebben dan ook
regelmatig bij de een of ander heerlijk gegeten. Hopelijk lukt het nog eens  in
Houten te gaan eten, want die semi-afspraak is volgens mij al gemaakt voordat
Petra zwanger was van Maaike…. En van jou, Karin, heb ik nog een motorritje
te goed. (Als ik dat nog durf…)
Tony, onze eiwit-goeroe, ik kwam regelmatig bij je langs met blots die het
aanzien niet waard waren. Elke keer bracht je weer het geduld op om samen
alle technische aspecten van de proef langs te gaan. Maar zoals zo vaak in de
wetenschap was het telkens een kwestie van gewoon overdoen. Waarom het
de ene keer wel lukt en de andere keer niet, daar zullen we wel nooit
achterkomen.
Last but surely not least, wil ik Ronald bedanken, mijn rots in de branding, mijn
veilige haven in woest water. Hoe vaak heb jij wel niet te lijden gehad onder
mijn slechte humeur als het weer eens niet ging met de experimenten. Hoe
vaak heb ik je in de weekenden meegesleept naar het lab, die plek waar je
nooit meer wilde komen. Ook was jij het vaak niet eens met de manier waarop
ik reageerde op het wel en wee binnen mijn AIO-tijd en vond je dat ik meer
voor mezelf moest opkomen. Helaas heb ik dat nooit van je kunnen leren, daar
was en ben ik gewoon een te grote schijterd voor. Maar hopelijk ben je
uiteindelijk toch wel trots op me en wat ik uiteindelijk op mijn manier toch heb
bereikt. Wel ben ik bang dat ik ook tijdens de komende twee jaar je geduld nog
regelmatig op de proef zal stellen.
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“Vriendschap is een kostbaar goed, niet alleen in de schaduwkant maar ook in
de zonnige zijde van het leven. En dankzij een gunstige ordening der dingen
bestaat het grootste deel van het leven uit zonneschijn.”
(Thomas Jefferson)
___________________________________________________________CurriculumVita
e
105
Curriculum Vitae
Mascha van Noort werd ter wereld gebracht op 28 maart 1974 te Eindhoven.
Na haar middelbare school te zijn begonnen in Mödling op het
Bundesgymnasium/ Bundesrealgymnasium, heeft ze haar VWO diploma
behaald op het St. Laurenscollege te Rotterdam in 1992. Aansluitend zette zij
haar opleiding voort aan de Universiteit Utrecht, waar de studie Medische
Biologie werd gevolgd. De propedeuse werd binnen een jaar met genoegen
behaald. De eerste stage binnen deze opleiding werd gelopen bij de vakgroep
Neurologie, UMC Utrecht, onder begeleiding van Prof. Dr. Dop Bär. Hier werd
onderzocht welke invloed radicalen hebben op ischemische neuronen en of
radicalen zijn betrokken bij de pathogenese van amyotrofische lateraal
sclerose. Het hoofdvak werd gedaan bij de vakgroep Pathologie, onder
begeleiding van Dr. Marcel Tilanus. Het onderwerp van deze stage was de
regulatie van HLA expressie op tumoren. Onderdeel van het hoofdvak was een
scriptie over de transcriptie regulatie van HLA moleculen. Vervolgens verrichte
zij binnen dit project ook onderzoek in Granada, Spanje, gedurende 5 maanden
onder auspiciën van Prof. Dr. Frederico Garrido en Dr. Pacco Ruiz Cabello. Dit
verblijf werd gefinancierd door het Koningin Wilhelmina Fonds. Na het halen
van het doctoraal examen in augustus 1997, begon ze aan een tijdelijk
contract aan de vakgroep Immunologie, UMC Utrecht, bij Prof. Dr. Hans
Clevers, waarna ze vanaf 1 februari 1998 als OIO werkzaam is. Haar
promotieonderzoek behelsde onder andere het aken van het aABC antilichaam,
waarmee actief signalerend b-catenine gevolgd kan worden, zoals uitgebreid is
beschreven in dit proefschrift. Vanaf maart 2002 zet ze haar wetenschappelijke
loopbaan voort bij de vakgroep Immunologie van de Erasmus Universiteit
Rotterdam onder Prof. Dr. Van Dongen en Dr. Frank Staal. Hier zal zij zich
gaan bezighouden met het maken van antistoffen tegen breukpuntantigenen,
die voorkomen bij verschillende leukemiën.
